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History and Origin 
CHAPTER I 
INTRODUCTION 
PARA THYROID HORMONE 
Surgeons in the early nineteenth century noted that a 
ca.mon after-effect of the removal of the thyroid was the 
development of a neuromuscular syndrome ranging trOll mild muscle 
spasms to severe tetany. Approximately 50 years later the 
discrete entities which were called the parathyroid glands and 
believed to be non-functional, were found closely associated with 
the thyroid gland. In 1880 Sandatr=. (102) first discovered the 
external parathyroid glands and in 1891 their existence was 
confirmed by Gley (46). The discovery of the internal parathy• 
roid glands was d-.onstrated by Kobn in 1895 (64). Vaasale and 
Generali (115) established the relationship between the para-
thyroid glands and tetany. Thyroidectomy performed without 
cognizance of the parathyroid glands resulted in tetany 
attributed to the raaoval of the thyroid aland. In 1908 
MacCallum and Voeatlin (74) established the relationship between 
the nervous manifestations of parathyroidectomy and the level of 
serum calcium. Skeletal chana•• incident to hyperparathyroidism, 
although imperfectly understood, were first described by Von 
Recklin&bauaen ( 116) • 
During 1925 the parathyroid aland attained the status of an 
endocrine organ when Hanson (49) and Collip (28) independently 
accomplished the isolation of a physiologically active extract 
2. 
fran the glands. Thus was ushered in the modern era of 
parathyroid hormone research in which the chemistry and mode of 
action of parathyroid hormone have been intensely studied. 
The site of secretion and storage of parathyroid has been 
linked to the chief cells of the parathyroid gland. Using the 
technique of Lmmunofluorescence, Hargis et al. (50) demonstrated 
parathyroid hormone overlying the cytoplasm of the chief cells 
of bovine, human, and rat parathyroid glands. This technique 
showed no specific staining with oxyphil cells in human tissue, 
a cell type previously linked to parathyroid hormone secretion 
and storage. 
The secretion of the hypercalcemic agent, parathyroid 
hormone, is governed directly by the concentration of calcium ion 
in blood (22, JO, SO, 86, 104). This relationship has been 
conclusively shown by measuring plasma hormone concentrations 
following changes in glandular plaama calcium concentration 
effected by perfusion. care et al. (22.) using radioimmunoloaieal 
assay techniques demonstrated that perfusion of goat parathyroid 
gland with blood containing 14'- calcium led to an 80% decrease 
in parathyroid hormone secretion within one-half hour. Subse-
quent perfusion with low-calcium blood led to a rapid increase in 
hormone secretion to seven times the suppressed value. Recently, 
Ramberg et al. (93) have presented data to indi.cate that para-
thyroid hormone is continuously secreted at a rate which is 
proportional to plasma calcium coneentrat:ion. 
3. 
l"lost of the current assay procedures employ a. modification 
of the Munson technique (81) which utilizes the parathyroid 
hormone-induced mobilization of calcium into the blood of rats 
as the parameter for assay. The use of thyroparathyroidecto-
mized animals has greatly improved the index of preeision of 
thle assay due to the lack of interference from thyrocalcitonin 
secretion which might be expected to supress increases in plasma 
calcium following the administration of parathyroid hormone. 
The assay is sensitive to 2 USP units of parathyroid extract. 
The concentration of parathyroid hormone in plasma can be 
measured by a much more sensitive technique developed by Berson 
et al. (14). The assay employs the principle of competitive 
inhibition of binding of highly purified parathyroid hormone, 
131 labeled with I, to specific hormone antibodies which are 
produced in guinea pig. Extracts of the serum or tissue to be 
assayed displaces the antibody bound 131 t-labeled bovine 
parathyroid hormone according to the respective concentration 
of parathyroid hormone in the test material. Such an assay can 
detect as little as 10 uug of parathyroid hormone. 
Chemistry 
Nearly all studies concerning the isolation and character-
ization of parathyroid hormone have been confined to that 
entity extracted from bovine &lands {7, 52, 73, 90, 97). Recent 
techniques employ a three stage isolation procedure: 1) acetone 
. 4. 
dahydr.ation aDd chloroform defa~tina of freshly frozen 
parathyroid alancla, 2) extra~1on of the active priaoiple fraa 
these acetone powders with either 9~ phenol or a mixture of 
8 M urea - 0.2 ! HCl - 0.1 H cysteine followad by solvent and 
salt fractionation, 3) INOeeaaive ael filtrations of the eru4e 
TCA precipitate uains various aradea of Sepbadex and finally 
carboxyaetb¥1celluloae. 
The bomone molaoule obtalnecl by either phenol or tbe urea -
HCl • cysteine method ia bioloaieally &ad chemically the aame 
(52). Potts and Aurbaoh (90) ha,. reported tbe isolation of a 
minor c•ponent la the eaC'b.,.ethyloellulose material which il 
biologically, laauaoahaaloally, &ad cbealoally atmilar to the 
major caapoaeat but baa a allahtly different amino composition. 
These workers have preaeat .. the only detailed reperts coaoend.q 
the priaary aaiao aeicl aequeace of parathyroid hontone. They 
have isolated aDd detenlaecl the sequence of a car:boxytarainal 
peptide conaiatt.na of 20 ad . .Do ae1c1 naictuea which retains •oat 
of the ~aologleal activity and 301 of the biological activity 
of the parent ho~. 
The loss of bioloat.cal activt.ty of pa&"ath)'l!'old honone by 
\ 
tnatllent with H24Ja or perfenal.e ae141 baa been eloa,ly correlated 
vith the rate of ox1dat1cnl of aethloalae naiduea to .. tbioalfte 
sulfoxide or: me1:b1onlne sulfone (95). Of the two aethionille 
realduea present l.a par:athyroid hormone, only one is belieV«<d to 
be necesaar:y for bioloaical aotl~ty (90, 107). 
. s. 
Biological Reaponae aDd Mode of Action 
1 t baa been c l•rly shown that parathyroid b.oz:mone has 
a direct action on both bone anc:l kidney ( 6, 89) aDd. to soae 
extent on the gastrointestinal tract. Tho major function of the 
hos:mone i.a to maintain the caleiua ion activity of the extra• 
cellular fluids within physi.olo&ical U.aita. The total effect 
of the hormone on all three major taraet orsans 1a to conserve 
body stores of calcium. 
Rasausaen (94) pnsentecl one of the first detailed reports 
U .. nldn& parathyroid homcme and the absorption of calcium from 
the gastrointestinal tc-act. He fO\md tb.&t parathyr:oidectcmy 
consistently decreased the abaorptioa of calcium from the aut 
of axperimatal animals. It was ocmcluded tbat paa:-athyroid 
hormone is neoeasary for normal ealeium absorption. Birge, Peek 
and !HidD (16) reported that calcium absorption ia increased ln 
huma.n1 with hyperparathyroidism. 
However, in order for parathyroid bOJ:mone to act on the 
abaorptiOA of calcium from saatrolntestinal tract, vitamin D 
must be present in aufflcieftt quantity (32). The administration 
of parathyroid hormone bas no effect in attmulatina the absorp-
tion of oalctl\D fr• the gut ot vitamla D•deficiat ard.mala (SS). 
Converaly thyroparathyroidecto.y ot vlc .. ia 0•4efio1«Dt an1mala 
cloea not deol'ease the absorption of calcium fr<a the aut aa it 
would in nos:mal anlllala. lt appears that parathyroid homoae 
actlon and vitamla D are int~tely aesoelated with respect to 
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calcium absorption. 
The administration of parathyroid hormone to mammals 
produces a rapid increase in urinary excretion of phosphate and 
an initial decreased excretion of calcium and magnesium. Beuter 
et al. (lS) showed that a reduced urinary excretion of phosphate 
followed parathyroidectomy. They also deaonstrated that in-
jection of parathyroid extract produced a hyperphosphaturia. 
Ito et al. (S9) found a 701 increase in the tubular reabsorption 
of phosphate following parathyroidectomy. 
There is evidence to iDdicate that changes in glomerular 
filtration rate are not respon•ible for hormonally-induced 
changes in ion excretion and. that the renal tubule is the site 
at Which the hormone acts (SS, 77). Although the exact site of 
parathyroid action upon the renal tubule remains unsettled, most 
investigators favor the view tbat its major action is the 
inhibition of proximal tubular reabsorption of phosphate (23, 54, 
77). Others bave indicated that the action of parathyroid 
hormone may involve active phosphate secretion in the distal 
tubules. The studies of Nicholson (83) and Nicholson and 
Shepherd (84) on the nephron of the dog kidney which was select-
ively damaged by nephrotoxic agents augested hormone stimulation 
of phosphate secretion. In either case the postulated mechanism 
of hormone action would be to increase the concentration of 
inorganic phosphate within renal tubular cells. In the proximal 
tubule, this would lead to diminished tubular reabsorption by 
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increasin& the concentration gradient to be surmounted at the 
lumi.nal border {84). and at the distal site where luminal 
phosphate concentration is lower it could lead to phosphate 
secretion. 
Action in Bone 
Since the skeletal system contains 98'%. of the body stores 
of calcium• parathyroid hormone regulation of plasma calcium 
must in some way involve bone. Parathyroid hormone has two 
major direct effects on bone: to prcmote resorption and to 
inhibit collagen synthesis in the formation of bone. Gaillard 
(44) using the technique of bone tissue culture demonstrated 
these effects quite clearly. Incubation of explanted mouse 
bone•rudLments with relatively high concentrations of parathy-
roid extract (Lilly) produced well-defined histological changes 
in bona. Microscopic examination of the bone shaft revealed a 
loss of osteoblast•• an increased number of osteoclasts, and 
active resorption. Rat.sz (91) confirmed these observations 
using bone rudiments pre-labeled with calcium-45. The calcium 
of the medium in which these rudiments were incubated with 
parathyroid hormone. was consistently higher indicating that the 
hormone was producing active resorption in tissue culture .. 
Hiatolo;1eally1 this resorption was associated with osteoclastic 
proliferation and decreased osteoblastic activity. 
Talmage and Elliott (lOS) by applying the technique of 
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peritoneal lava!1e, d81lonstrated that parathyroidectomized rata 
could mobilize calcium from bcme at the same rate as do normal 
rata. They concluded that the site of action of parathyroid 
hormone must be on the deeper trabeculae and not on the moat 
recently deposited calcium. There ia aeneral acceptance that 
the regulation of blood calcium ia physiologically a two-fold 
proeeaa: blood • bone ion transfer which is responsible for 
minute to minute baaeoataaia and a slower acting parathyroid 
hormone component which is responsible for hour to hour 
homeostasis. The blood - bone ion transfer affects only the 
labile calci.UIIl which occurs in newly fot:'mlng and surface areas 
of bone while the parathyroid function affects the stable 
calcium located in the well-established mineralized areas of 
bone. 
It baa been shown that parathyroid extract and the metabo-
lia of citric acid are intimately associated. Bone is the 
principal body reaevoir of citric acid. Citrate aulysls of 
alcohol extract of bone obtained from parathyroid extract-treated 
and no~al animals, revealed a significant increase in citrate 
extractable from the bone of parathyroid extract•treated an~ls 
(36). Others (77) have noted an increase in racU.oactive citrate 
from pyruv.ate-2-14c during the incubation of freshly isolated 
bone frasmeots obtained from parathyroid extract-treated an~als. 
The data was interpreted to mean that parathyroid extract 
stimulates the fOJ:m&tion of citrate from its precursors. 
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However, J:!1 '!'\tro studies by Vaea and Nichols (100, 113) 
indicate that the metaboliam of citrate in mouse metaphysis 
occurs at about ten times the rate of synthesis. Since bone 
cella have the capacity to metabolize the acid more rapidly than 
it can be formed. it would be more likely that t:he parathyroid 
extract effect in bone is on metabolism rather than synthesis. 
Bone cella can indeed ayntheaize citric acid, but elevated 
levels of citrate obtained upon parathyroid extract administra-
tion cannot be entirely attributed to increased synthesis; they 
are probably due to a blocking of citrate metabolism in same 
manner. 
There have been ae.,.ral reports on the influence of para-
thyroid extract on bone metabolism using the techniques of both 
short term and lona incubations. Cohn (2.7) and Conn and 
Foracher {26) have studied the production of labeled carbon 
dioxide from Krebs cycle and alycolytic intar.mediatea by rabbit 
femur alices prepared from parathyroid extract-treated and 
control animals. The production of labeled carbon dioxide from 
Krebs cycle inter.aediatea such aa citrate, auccinate, and 
fumarate was reduced significantly by femurs of the treated 
animals. However, the release of labeled carbon dioxide from 
glucose was increased slsnificantly by bone slices obtained from 
parathyroid extract-treated antmals. 
Mecca et al. (78) studied the same parameters as did Cohn 
but used a system of embryoaic bone in au lt:ura for several daya 
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with varying amounts of parathyroid extract. The metabolism of 
labeled ei~rate in parathyroid extract-treated cultures was 
depressed in comparison \rl.t.h eontrol preparations. However • 
similar studies utilizing radioactive glucose and pyruvate as 
substrates showed no effect with respect to the release of 
labeled carbon dioxide. They also prepared nomogenatea from 
calvaria cultures and used them to study the release of labeled 
carbon dioxide from citrate. No differences were detected 
between control and paratbTroid extract-treated calvaria homo-
senates until nicotinamide adenine dinucleotide phosphate {NADP) 
was added to the bone preparation. With this addition a decrease 
in the release of labeled carbon dioxide from parathyroid 
extract•treated calvaria was noted. The addition of t~DP waa 
probably required because the preparation of the homogenate no 
doubt disrupted the cellular or&anization• and not because of any 
altered parathyroid extract•induced effect produced in the 
hOi:IOgenate. 
There are then two distinct cellular processes in bone 
which haw been observed experimentally to be influenced by 
parathyroid extract: bone ~sorption and bone metabolism. 
Resorption is a complex process involving the diaaolution 
of both mineral and oraanic matrix. There is no agreement aa to 
which is initially removed. The r•oval of the or&&l'lic m.atrix 
is in all probability an enzymic process, and there are two ways 
at least in which parathyroid hormone may control it: by 
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inducing the ayn~heaia of new enzymes, or by acti vatins latent 
ones already present ill acne inactive form. There ia some 
evidence to support each viewpoiftt. 
Evidence in favor of the first alternative are the obser• 
vations that the administration of inhibitors of RNA or protein 
synthesis (actinomycin D or purOilycin) inhibits the bone calcium 
mobiltzin& effeots of parathyroid hormone ia :dr.:f2 (69. 96, 106) 
and ia Dt1'9 (44, 91 ). lD y:l~r9 stucliea by R.aisz (92) indicate 
the parath)rZ'oid homone•induced nlease of calcium is biphasic: 
an early release wbich ia not inhibited by actinomycin D and a 
later progressive release whJ.ah is actlru::nycin D sensitive. 
Ra•ussaa ( 96) aubstantiated this obaervatiOD 111 .D,m when he 
observed that parathyroid hormone adainistration to actinGmycin 
D•treated animals caused an early rise in plasma calcium which 
was not sustained aa in control animals. These data augest 
that this hoaaone baa aa tramec.tlate effect upon bone resorption 
which does not involve a change in enz,ae ~thesis and a later 
effect which 4oea. Raiaz (92) also reported an apparent 
competition between actina.ycin D and parathyroid h~one by 
d•onatratlns that i.ru::reaaing the concentration of parathyroid 
honone overc•ea the actlnCIIlycin D inhibition. He has suaaeated 
that the two agents coapete for a binding site on DNA. 
Vaea (114) baa presented e'Vldence which indicates that bone 
resorption may be brought about by the ac~ivation of latent 
eDZ)'Illes. He baa shown that bone cella contain •-brane•bound 
12. 
cytoplasmic organelles called lysosames, which contain a number 
of acid hydrolase& capable of participating in the hydrolysis 
of bone matrix. Activation of the lysosomal-bound enzymes 
would require only the rupture of the membrane. Vaes has 
demonstrated that at least sa.e of these enzymes are released by 
bone in tissue culture under the influence of parathyroid 
hormone. His premise is that in a suitable acid environment 
resulting from the accumulation of organic acids, hydrolysis of 
the matrix can readily occur. He proposes that the action of 
parathyroid hormone is similar in this respect to that of 
vitamin A which has been shown to promote the release of lysoso-
mal enzymes in cartilage (39). 
To understand the mechaniam of parathyroid hormone action 
it is necessary to determine the effects of the hormone at the 
cellular level, especially in light of evidence linkins para-
thyroid hormone and RNA synthesis. This is extremely difficult 
to show in bone, mainly because of the low cell density and the 
marked heteroseneity of the cell population in this tissue. 
Consequently, studies of this type have been approached using 
homogeneous cell preparations (19, 111). 
Borle and Neuman (19) have shown that HeLa cells srown in 
monolayer cultures resorb dead bone chips when incubated with 
parathyroid extract. Morphological changes in cell membrane, a 
decreased cellular calcium, and decreased adhesiveness of the 
cells to glass were also noted as a result of paratb¥roid 
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extract treatment. Similarly, Tenenhouse, Meier, and 
Rasmussen (111} have demonstrated that Ehrlich acites cells 
respond to parathyroid hormone. A two phase system was 
utilized in which cella were first incubated with the hormone, 
then the supernatant from the first phase was incubated with 
45ca-labeled non-viable bone powder. The release of 45ea was 
used as a measure of parathyroid hormone activity. As little 
as 1 ug per ml of parathyroid hormone caused a significant 
4.5 increase in ca release. In this particular system, there is 
no contact between cella and bone powder. The stimulation of 
calcium release is therefore the result of the action of some 
factor released by the cells under the influence of parathyroid 
hormone. This effect is prevented by the addition of actin• 
omycin D to the first phase. This observation suggests that 
RNA and protein synthesis are required for the production of 
the calcium-releasing factor. 
It is possible that bone lysosome, protein synthesis, and 
metabolism are int~ately connected in the parathyroid hormone 
function sequence. Parathyroid hormone causes the release of 
latent and/or synthesis of bone destroying enzymes. The 
accumulation of organic acids attributed to parathyroid hormone 
activity will maintain an acidic media at the resorptive site 
which in turn ensures the optimal activity of the bone des-
troying acid hydrolase&. Besides ensuring optimal enzyme 
activity, the accumulation of acid products, particularly 
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citrate as sur,?;ested by Neuman and Nfrull\llll'> ( 82) would lead to 
the physical (non-enzymatic) di.ssolut:ton nf bone mineral. The 
citrate ion :ts a potent chelator of calcium ion as well as 
being capable of ionizing three moles of hydrogen per mole of 
citrate anion. Blood citrate concentrations are sensitive to 
the parathyroid sta~1s of the animal. L'Heureux and Roth (72) 
reported increases in both serum calcium and citrate after 
injection of parathyroid extract to normal rats. Parathyroid 
function dependent concentrations of bone lactate and one 
carbon acids also play a significant role in the resorptive 
acidification process. 
IS. 
THYROCALCITONIN 
History and Origin 
The events leading to the discovery of a hypocalcemic 
principle believed to be involved in blood calcium homeostasis 
were set ift motion early in 1961. Copp (30) observed that 
injections of certain preparation• of commercial parathyroid 
extract produced an initial hypocalcemic reaponse prior to the 
expected hypercalceaia in the teat an~al. Perfusion of the 
parathyroid-thyroid apparatua in tbe dog with hypercalcemic 
blood resulted in an overall decrease in serum calcium (31). 
Copp concluded that the parathyroid gland was tbe source of a 
hypocalcemic principle which he named "calcitonin•, since 
removal of the parathyroid &land before perfusion abolished the 
obaerved response. Kumar et al. (67) originally presented 
evidence which confirmed the parathyroid origin of the hypo-
calcemic agent, but later indicated that the thyroid was the 
primary aource of calcitonin (68). 
There is now a general consensus with the pr•iae 
originally presented by Hirsch (SS) that the thyroid aland is 
the prineipa 1 source of a hypocale•ie honone named thyro-
calcitonin (TCT) as opposed to the postulated parathyroid 
hypocalcemic factor, calcitonin (13, 20, 4S, 47, 112). 
Thyrocalcitonin baa been isolated in quantities sufficient for 
assay from the thyroid glanda of several species (47) includin& 
the rat, dog, goat 1 ox, monkey and human ( 1 ,3, S3, S6}. 
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Hagis ( 48) by means of immunof luoresence technique, 
detected thyrocalcitonin in the eytoplasm of all epithelial 
cella of porcine thyroid glands. SiMilar teehniquea applied to 
porcine parathyroid glands did not detect the presence of 
thyrocalcitonin. Pearse et al. (87) hAve postulated that the 
thyroid C cella manufacture and store thyrocalcitonin in a form 
that is available for rapid release. 
Recent developments indicate the possibility of the 
existence of two different hypocalcemic factors in the calcium 
homeostatic system calcitonin frcm tl\e parathyroid gland (4, 21) 
and thyrocalcitonin from the thyroid aland. 
Aaaay 
The~:e ia no atandarcS uait of tb.y~:oealcitoain acti vl.ty, but 
rather such unite are arbit~:arily defined in accordance with a 
doae•reaponae relationahip of the paJ:tieula~: aaaay procedure 
under coaaideratioa (56 1 68, 103). Moat procedure• aeaaure the 
fall in serum calcium aa the parameteJ: for aaaay. The Medical 
Reaearch Council of &ritain in an effort to eatabliah a uniform 
unit of activity baa prepared for diatribution viala coatainins 
a thyrocalcitonin preparation of a defined potency of one M.R.C. 
unit (56). Tbe moat salient characteristic obaer.ed in 
thyroealcitonin assay ia the rapid onset of a deer•••• in serum 
calcium of the teat aotmala. ln fusion of 50 mug/min into the 
tail vein of a 100 &r• albino rat will produce a 1% decrease 
in serum calcium within 60 minutes ( 68). 
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CheaiatJ:Y 
Tb¥rocalcitonin ia prepared from acid extracts of thyroid 
glanda, u.ually porcine thyroid alanda (47, 53, 8S). The acid 
extract ia subjected to aolveat and aalt fractionation and ael 
filtration to produce a hiahly purified product. Porcine 
thyrocalcitonin obtained by four different approaches uain& the 
above procedure (S3) ia a ainale obain polypeptide of a 
molecular wei&ht ranae 5,200 t 800. An appreciable amount of 
bioloaical activity of porcine thyrocalcitonin ia lost upon 
treatJaent of the homone with hydroaen peroxide, and n • brcaao-
wcclnamlde ( 108). 
Biological Reaponae and Mode of Action 
Infusion of thyrocalcitonin in rata will produce hypophoa-
phat81Dia cODccaitant 'with b.ypoealc•ia aa well aa a paaaive 
hypoealciuria and a abort t em hyperphoaphaturla ( 88, 98). 
Thyrocalcitonin markedly inhibits bone reaorption both in vi$£0 
and in l1!2 (43, 45, S1, 60, 63, 75, 76). Riatoloalcal 
ex•lnatlon of bone culture• incubated with parathyroid hormone 
and thyroealcitcmin, c.t•onatl'ated that thyrocalcitonin can 
arrest pal'athyroid hormone induced bone reaorption ( 43, 4S). 
Injection of thyrocalcitonin into aataala wboae bones are pre-
labeled with 4Sca produces a decreaae in the turnover rate of 
45ea ia both the labile and atable fl'actiona of bone calcium 
(S7, 60, 63). How.ver, the inhibition ia more pronounced in the 
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stable fraction of bone (57). Using the technique of lavage 
removal of calcb.lm from bone, Klein et al. (62) observed that 
thyrocalcitonin produced a marked supreasion in the removal of 
calcium. These observations tmplicate bone and possibly the 
kidney as target organa of t~rocalcitanin. Another potential 
tar&et organ of calcium homeostasis, the aastro-intestinal 
tract, has been show to be unnecessary for thyrocalcitonin 
action (2). Studies em the influence of thyrocalcitonin on the 
lumen to plasma ion flux of leola ted pat aepents d-.onatrated 
a statistically insiantfieant decrease in flux (66). Recycling 
a fluid of known calcium concentration through the gut loops of 
anesthetized doas injected with thyrocalcitonin produced a rapid 
fall in aerwa caleb• but no chana• in aut calciUII concatra-
tion (65). The questicm whether the kidney is a taraet oraan 
at all remains controversial. Reports can be culled from the 
literature which cover an entire spectrua of results with 
respect to phosphate excretion and thyrocalcitonin. Some 
workers ( 79, 99, 100) reported experlaents which detected a 
definite relationahlp be~en thyrocalcitonin aDd b¥Perphoa-
phaturia. Othera ( 98) have d•onatrated a short term byper-
phoaphaturia, while Pechet et al. (88) report that thyrocalci• 
tonln lnjectl.on produces decreased exeretlon of both calcba 
and phosphate in rate. 
Sl.nce parathyroid hormone and tbyrocalcttontn have directly 
opposite responses with respect to bone resorption, one ai&ht 
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expect that thyrocalcitonin inhibits the secretion of or in 
some way inacti. vataa parathyroid hormone. This does not seem 
to be the case since thyrocalcitonin is effective in parathy-
roidectomized antmals (2, 55) and there is no evidence for the 
thyrocalcitonin inactivation of parathyroid hormone (2). The 
primary site of hypocalcemic actioa of the boraone appears to 
be at some ataae in the resorptive process of bone (62). 
Thyrocalcitonin and parathyroid h~an• probably do not caapete 
at the aa.e site in the resorptive process (SS), but rather if 
one eoa.aiders bone resorption a stepwise procesa, thyrocalcitonin 
exerts ita effect at a step oeeurrina earlier in the resorptive 
proeeaa to that aite which is aenaltiw to the hypercalcemic 
hoxmoae, parathyroid horaorae. 
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BONE METABOLISM 1! VITRO 
Although bone contains several heterogeneous and quite 
distinct cell types it is believed that the metabolic pathways 
in these cella are basically the same. The overall pattern of 
glucose metabolism in freehly isolated bone differs very 
slightly fraa tbat pattern of slueoae metabolism which would 
be found in any typical cell (26). There is a difference in 
the prtmary metabolic end prOduct of bone cell metaboliam and 
that of ordinary tissue cella. The faet that S0-60% of the 
metabolized alucoae is converted into lactic acid is believed 
to be a refleetion of the low oxyaen tension in bone cells 
caused by the isolation and aluaaiah circulation in the 
riaversian Systems. Freshly isolated bema ill a simple buffer 
exhibits an anaerobic pattern of slucoaa metabolism (17 • 26) 
eve in the presence of oxyaea. 
The anaerobic nat:uJ:a of boaa metabolism perhaps leases 
the importance of Krebs cycle activity, but it doea not entirely 
obliterate ita importance. The classic acid resorption theory 
of bone relies on the ability of citrate as a potent chelator 
of calcium ion. Citric acid wae believed to play an ~portant 
role in parathyroid hormone resulation of bone resorption (82). 
Moat of the lactic acid fol!"llled in bcme will eventually be 
metabolized via the Krebs-citric acid cycle. 
The met&boU.em of bone is not exclueively liaited to organic 
acids. Skeletal tissue contains coasiderable lipid of diverse 
21. 
types (37, 71). It baa been shown lipids can bind both calcium 
and phosphate (9. 40, 61). However, the exact role of lipid in 
bone is not known. A lipid material has bean demonstrated at 
the sites of active calcification (58). This same unknown 
lipid material disappears from rachitic bone only to reappear 
when calcification is stimulated by vl.tamin D. The lipid 
material was not as demonstrable in older more calcified 
skeletal tissue. 
CI.'Uess and Clark. (33) noted that the lipid composition of 
bone vas altered by toxic doses of vitamin 0 or vitamin A. 
Administration of vit•irl A decreased the total fatty acid 
conttmt of cortl.eal bone while vitamin D wa1 observed to increase 
trialyceridea, esterified cholesterol and phospholipids in bone. 
Protein and •lao acid metaboli• 1.a bone are important in 
the fomation of the orsarli.c eollagea aatrix. Collaaen syn-
thesis in isolatecl bone aepen.ts will COiltiaue for at least 
eisht hours is Xitro (34, 41). Collagen ia formed in cella and 
is released as a relatively stable component of the organic 
matrix. Bone matrix synthesis is OXY'&tm dependant, since 
collasen synthesia is stimulated by glueoae and inhibited by 
anaerobiosis. 
There have been two aeneral approaches in the atudy of bone 
metabolism 1g ~s;o; namely, the use of freshly isoLated bone 
segments and the use of bone tissue cultures. Each of theee 
technique• have inherent advantaaea and diaavantagea. 
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Freshly isolated bone fragments are usually employed in 
short term experiments. The short term aspect allows a precise 
control of incubation medium and allows one to study tissue 
performing a wide variety of functions; glycolysis, amino acid 
transport, fat synthesis and the formation of collagen. The 
less durable cells of the isolated fragments die soon after 
isolation. The overall viable state appears to be 6 - 12 hours 
in which the initial metabolism of surviving bone approximates 
the true in vivo state of metabolism. 
--
The prolonged term incubation of bone cell cultures 
involves complex factors. The consistency of the media 
necessary to support such an incubation is quite difficult to 
control owing to the presence of inumerable constituents. Most 
synthetic tissue culture media require the addition of serum. 
This necessitates obtainin0 a uniform supply of serum from a 
single source in order to prepare consistent incubation media 
over a period of time. 
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Statement of the Problem 
There ia considerable evidence which indicates that para-
thyroid hormone (PTH) and thyrocalcltonill (TCT) have a direct 
action on bone, the principal taraet oraan of these two 
calciua reaulatins hononea. Ntaeroua reports have appeared 
coaeemins the relationabi.p betveera parathyroid extract (PTE) 
and the metaboli.. of alucoae and oraanic acids in bone. 
However, purified parathyroid homODe does not influence 
metaboliaa AD Xilto ( S2) a a indicated in the Ehrlich asci tea 
carcin-.a cell aaaay. Thia assay aeaaurea the flux in production 
of 14~ fro. alueoae-6-14c or p,yruvate-3-14c in tuaor cella 
incubated with peptidea of variable aetabolic activity. PTE 
and non-calcium aobilizina fractions obtained durin& the 
purificatiOD of PTI will stimulate the production of 14co2 frOil 
the aforalentioaed aubatn.tea but purified PTH baa no effect. 
There have been no reports to date cODoer:aina the relationship 
be~en tbe thyroealeitonia aDd the oxidation of substrates. 
lt is currently tHllieved that the metaboliam of oraanic 
acicla in bone .ay not eonatitute a direct role in the aechanlea 
of acticm of calcium hCIIIleoataaia aa previously proposed (82), 
but rather the releaae aad ayntbesia of heme deatroyiq eDZJ'IIleS 
(114) may be the primary inU:iator:a of the hyperealc-ic 
reaponae. 
The postulate of N8Uflan and Neuman ( 82) indicated that PTH 
produced ita hyperealcaaic action by inoreaaln& localized 
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acidity in bone via PTH-induced alteration in the rate of 
accumulation of acid products of bone metabolism which would 
dissolve bone mineral. PTH could increase acidity at the 
resorptiva site by either increasins the metaboli.a of alucose 
to orsanic acids and COz or by blockina the oxidation of organic 
acids so as to cause their aecuraulaticm. However, recent 
evideDce indicates that bone resorption is not quite as a imp le 
as the procaas outlined by Neuman and Neuman. Many cmzymes 
have been ahown to be involved in resorption (114). PTH action 
bas b-n shown to be dependent on m•IUfA synthesis ( 91 ) indicating 
that the synthesis of protein, probably enzysaea, is involved in 
the raecb.aai• of action of PTH. 
Since the hJpercalc .. io principle• parathyroid hor.mone, 
does not affect oxidation of substrate .111 yJ.tn, it would be of 
interest to discover the aaent wbich does produce the fluctua• 
tions in metaboli.. of alueoae and oraanie acids commonly 
associated with the injection of PTE aad PTH, and the relative 
iaportaraee of thue fUftcticma with reference to the aechanisa 
of action of the hypercalcemic response. Also, thyrocalcitonin 
bas a direct effect on bone (2) and is a PTH antaaonist (63) on 
many levels of PTH action. Information concemin& the unexplored 
relationship between TCT and bone metabolism might be helpful in 
establishing the relativa iaportance of alterations in the 
oxidation of alucoae and oraanic acids in the overall mechanism 
of calcium homeostasis. 
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The approach co the problem will be a modification of 
the one .. ployect by DeLoaa and L 1 Heureux ( 35). The bone 
preparation• will be uaad to relate the hormonally-induced 
metabolic pbanaaena (thyrocalcitonin and parathyroid extract 
induced alteration• in the evolution of C02 fro. aubatratea) 
with the hormonally-induced pbyaloloaical and hiatoloaical 
phenaaena (parathyroid extract and thyrocalcitonin altered levels 
of serum calcium). 
Two of the anataaieally diatlnct realons of femur will 
serve aa tlaaue apeoiaena; the cllapbyaia Uld epiphyeia. Theae 
two realona were choaan beoauae of aarked difference• in 
phyaieal atructure and eell cllatrli!NtiOD. It I.e poaaible that 
theae difference• say be reflected in the a~ion of PTE and 
TCT oa theae tlaauea. 
A lao the lnf luenoe of c:a lciua ion oa the oxidation of 
substrate will be studied la.an effort to establish a direct 
relation betweea substrate oxidation rate and calcium ion 
ccmc81ltratlon ill yJ.tro and J,a .D.:m• 
CHAPTER 11 
MATERIALS AND ,._iETHODS 
G19eral gxper~ental Prgsedyrt 
Male Holtzman albino rata wei&hing approximately 140 - 170 
grams were tbyroparathyroidectcmized in order to remove the 
influence of endogenous parathyroid hormone and thyrocalcitonin 
activity. The animals were prepared in the followirag manners in 
order to study the desired experlaental parameter. 
1. Parathyroid extract treatment and bone metabolism. 
The animals received two injections; experimental animals 
received 75 u.s.P. unite of Injection Parathyroid (Lilly) and 
control animals reoeiwd a comparable volume of vehicle at 24 
and 48 hours after suqery. The vehicle injected was that used 
in the commercial preparation of the extraet and was coaposed of 
1.67. alycerol, 0.2~ pheaol and o.~ sodium chloride. 
2. Calciwa ion com.....ntration and bone metabolism. 
ln order to study !J1 vivo calcium ion c:oncentration and bone 
metabolia. the aa~ala wwre maintaiued on calcium deficient diet 
and n<m~al diet for a period of cme week. The J.a Xi5E9 effect 
of ca lcl\.a icm on bon.e mecaboli• was studied by incubating bone 
tissue in media Wbich contained v.arioue concencrationa of 
caleium. 
3. PTE, PTE-TCT tS'e&t:ment and bone metabou .•• 
The animals were prepared as in procedure 1. However, twelve 
hour• after the last injec:ticm of PTE a group of PTE treated 
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an~als recei~ subsequent injections of TCT over a two hour 
period. 
In all the experiaents, the bone tissue was prepared auch 
in the same marmer. A weiped porticm of bone frapents or an 
aliquot of bone hc:aosen.ate was placed into a 25 ml incubation 
flask which coatalned a suitable ineubatlon m*.U .. UIIl. Fraputs 
and bomoaenates were prepared from both the diaphysis and 
epiphysis of f..ura obtailled fr• all teat an111lala. B.adioactive-
ly•labeled aubatrate waa added to each f laak and the f laak was 
sealed with a ~bber aep~ in which io inserted a plastic 
centerwell contalnina a 101 solution of KOH. The incubation was 
carried out in a shaker water bath at a t•perature of 37° C for 
a period of three hours. 
After three hours the nabla tlaaue was killed by the 
addition of 2 ml of 101 trichloroacetic acid to each flask. The 
10% solution of KOH whieb waa coatained in the cuterwell was 
transferred to a culture tube. The labeled carbon dioxide 
absorbed in the KOH solution was precipitated as bariua carbonate 
and the radioactivity waa detem.ined. 
SIJWM QALCIUM DETQH1RAJ:1Ql1 
A method of deteminina ionizable calcium in serum, which 
is essentially unaffected by oraanic materials present, bas been 
reported by Ashby and Roberta ( S). Thla method ia baaed upon 
the fact that at pH's above 12, calcein (an iainoacetate 
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derivative of fluorescein) fluoresces under lcma•wave ultra• 
violet li&ht only in the presence of free ealclua. In an 
analysis, a siven a.ount of ethyleaediaainetetraaeetic acid 
(EDTA) 11hich is in excess of that required to eompla all of the 
caleiua present is added to the ••ple. A amall 8t'llOUDt of 
cyanide is added to CGIIlpla any cropper or ira which is present. 
The solution is back•titratect vlth standard calcl.\8 soluticm 
wtth the calci\118 replacia& the ~Mpeei\S l.n aay mapeaium.-EDTA 
camplex which might have fonlad. WheD all of the EDTA has 
beocae COIDplexed with ealci\D, additicmal ealeiua will c•bine 
wtth ealoein eaueina fluoree..acet al\d the end poiat will bave 
been reached. Titratioaa must alao be performed on calcium-free 
••plea ia order to deter:alDe the total calcl'Uil biadina capacity 
of the EDTA aliquots. The aena calci\D level is determined 
from the difference betwaen the total oalelua binding capacity 
of the EDTA and the amount of calcium required to titrate the 
serum aaple. 
lour hundred microliters of blood sample were obtained from 
each rat by tail bleedina. The ••plea were placed in the 
refrigerator for a abort t~e before the clot vas separated by 
a five minute centrifugation in a leokaan/Spineo microfuge. 
Thi~y microliter aliquots of serum were added to microtitrator 
cups. To eaeb cup vas added 0.150 ml of 0.001 t{ EDTA, Ofte drop 
(about 60 ul) of dilute calceia indicator, 1 drop (about 30 ul) 
of 1'1. sodb• cyanide solutl.OI\1 and 1 drop (about 60 ul) of 1.0 
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! sodium ~droxide. Titration was performed with a micro-
titrator containing a 20.0 mg~ standard calcium solution. A 
lona-wave ultraviolet laap (Mineralisht• Model SL 3660) was 
placed about tvo inches above the titration cup. The standard 
calcium solution was added with continuous stirring until the 
green fluorescence which was obae~ no longer increased in 
intensity. The calciUI'I concentration of the sample is directly 
proportional to tbe difference in microliters of standard 
calcium required to titrate the sample and a water blank. A 
10.0 ma~ standard caleiu. solution was run with each group of 
samples and the calcl\D concentrations were calculated as 
follows: 
m&" ca leiu. • 1 0 ms~ x ais;olitU'I ftr iftM:f 
microliters or •& standard 
Where: 
microliters unknown • microliters of titrant required to 
titrate blank minus microliters of 
titrant required to titrate unknown 
sample 
microliters 10 ma~ • microliters of titrant required to 
standard 
titrante blank minus microliters of 
titrant required to titrate 10 m&1. 
standard 
figure I indicates the linear relationship between the 
microliters of titrant used aDd the concentration of calcium in 
solution. This is the standard calcium titration curve used to 
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TABLE I 
STANDARD TITRATION CURVE DA.TA FOR CALCIUM DETERMINATION 
Aetual Number of Microliters Microliters 
~lliY!I i&.:JlRlll !' II.UUt 'II.~EI•~ • 0 mill 
Oml" 6 + 30.7 - 0.2 
6 6 20.6 t o. 3 10.2 
8 6 17.3 t 0.4 13.4 
10 6 + 13.9 - 0.3 16.8 
12 6 + 10.8 - o.s 19.9 
14 6 + 7.5 - 0.2 23.3 
16 6 + 4.9 - 0.3 25.9 
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calculate serum calcium concentration for the antmala uaed in 
the esperinumta. The data for this standard curve appears in 
Table I. 
SilutiO!liS 
calceip eolutiS!!•gonc•tratt4. 0.2S a of powdered indictor was 
dissolved in 4.0 m.l of 1.0.! NaOH. When solution was 
c:Oilplete this was diluted to 100 ml with doubly distilled 
water. 
Calot\n indt.sasor solyt&s. o.s ml of the concentrated calcein 
solution vas diluted to 2S ml with doubly distilled water. 
C!li\UI 1tapdtrd eolutiop. 0.2497 1 of ov.n•dried calcium 
carbonate vas dissolved in 30 ml of 2 !! HCl and diluted to 
SOO ml with doubly distilled water. World.na solutions were 
prepared frOID this stook solution. 
!thyl!Btdlfll!ttttE!ICetls 11\d ttfD41£d• 0.375 & of EDTA 
dissolved in COz·free water to a total volUSBe of 1000 ml. 
fLgqD SAMPLII9: 
Blood aaaples were obtained fr• the tail of the rat. The 
rat was placed ia a reatrainlna caae aDd the tail severed 
approximately three quarters of an inch fro. the tip. Bleedin& 
was aided by "allk.ina" the tail in a proxillal to distal 
direction. Blood was collected in plastic m.lerotubes, and these 
were allowecl to stand at rooa t•perature for thirty minutes to 
oae hour to allow for clot formation and retraction. 
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Centrifugation was performed in a Beekman Spineo/Microfuse for 
two minutes. Supernatant serum was separated fro. centrifuaate 
and stored under refrigeration ln a aicrotube until analyzed. 
IHDOfABAIHXI91DMOO: 
Thyroparathyroldectcay at birth. results in a severe 
retardation of arowth. and skeletal developaent. The chana•• 
are leas severe if the operations are perfo~ed at later aaes 
and usually require a period of weeks to beccae aanifeat. 
The auraical tecblllque •ployed ln the tb.yroparath)'roid· 
•ct01117' of male albino rata i1 one o-.cmly •ployed in ftWIIaroua 
laboratories. Animals 120 - 140 grass ln velaht are anesthe-
tized vith a dose of aqueous n•butal solution in the proportion 
of 33 •a n•butal/Ka of body wal&ht. The rat la secured to an 
operating board and the head la kept extended by means of a 
rubber band which la looped over the upper iaeisora. A 'ftfttral 
midlin.e ak11l incision. is made aten.41n& sli&htly beyond the 
upper and lower boarders of the submaxillary aland. The 
salivary alanda are aently teased aaide aa any unneeeaaar,y 
trauma will cause severe blee41na and the underlylna musculature 
opened at the aidllne by blunt dissection. the lllUBCUlature 
~ediately aurroundlna tba traachaa ia teased apart at the 
midline and retracted • th.ua expos ina the two lobes and the 
isthmus of the thyroparathyroid apparatus. The alands are then 
carefully teased frcm the treachea. preferably intact (two lobes 
connected by the isthmus} to ensure camplateneaa of removal. 
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Af~er ~he removal of the &lands, a w.dge of sterile cotton 
is placed over the WOUrtd until the bleedina is assuaged. The 
co~ton ia r•oved and the wound ia eloaed by the use of Michel 
wound clips. 
The anl.mala require fr• three to six hours to recover 
fr• the anestheat.a. Those &ftimals Which developed difficulties 
in breathing or severe losa in weipt within two daya were not 
uaacl in the axperl.menta. Durin& the operation, clean but not 
neeeaaarily aseptio teebnique vaa •ployed. The rat does not 
readily become infected in the reaion of the neck. Overall, 
male albino rata within a weiaht ruse of 120 • 140 arama seem 
to respond better to surgery than beavler animals. In animala 
weisht.na lesa than 100 ara.a, the tbyro1d•paratbyroid apparatus 
is often difficult to find. 
IHI PRJfAMilQJ! 2l fMGMil!TS AND HgtOGIA"fADS QStt MI FR!YR 
Male Holtzmaa rata were etwmed by a sharp blow to the head 
and decapitated. A eemieircular 1nelalon was aade around the 
lea just below the pel'Vle. The akin wae pulled toward the foot 
exposlna the lllUsaulature of the thiah area. The tendon COil• 
nectina the epiphyala and a portlcm of the musculature was 
severed. The aevered tendon vaa araaped with forcepa and pulled 
toward the pelvis. This procedure tears away moat of the 
ventral musculature of the thi&h and expo••• the f•ur. The 
r•ainiq musculature was scraped away with a acalpel. The 
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femur was severed from the tibia and worked free fran the 
soeket in the pelvis. 
The extirpated femur was placed in ice-cold incubation 
media. The bone was ele&Ded of all adherent muscle, periosteum, 
and cartilage. The distal epiphysis is separated from the 
diaphysis. The prox~al epiphysis is also separated from the 
diaphysis, but it is discarded. The distal epipb7sis and 
diaphysis were split lonaitudiaally and the marrow r•oved by 
serapin& with the point of a scalpel and washina with isotonic 
saline. 
For the preparation of bone frasments, the aeetions of 
epiphysis and diaphysis were blotted dry and weighed on a 
Roller-Smith balance. Approximately lSO - 200 ms of the split 
bone sections were fra.-entized OD slaaa or lucite plate using 
a stainless steel scalpel and placed in a twenty•five ml 
iucubation flask containina 4.0 ml of incubation media. 
For the preparation of h•osenates 1 sections of epiphysis 
and diaphysis were placed in a bone disiatearinder (Kontes) 
with 10. 0 - 30.0 al of incubation media depend in& em the amount 
of bone to be h•oa .. ized. H•osenlzaticm was performed for 
five ad.DUtes or uratil no further contact between the disinte-
srinder and bone could be felt. 
HaaogeD&tes bave a milky appearance and settle out 
rapidly. While pipet~ing, the hellloaenate ia kept agitated with 
a masnetic stirrer. Whenever possible tiesue was maintained at 
36. 
0 
a temperature of 0 C during preparation. 
An estimation of the amount of material in any particular 
volume of homogenate was obtained by pipetting a 1.0 ml aliquot 
of homogenate on a preweighed planchet. The aliquot was dried 
on the planchet using a heat lamp. The planchet was weighed 
and the dry weight of the material in the aliquot determined by 
the weight difference of the planchet. This was necessary so 
that the data could be expressed according to 14caz evolved 
from substrate metabolized by an esttmated amount (dry weight) 
of bone present in the homogenate. 
PREPARATION OF lNCUBATIQl! MEDIUM 
The medium used in these experiments was prepared by 
mixing 232 ml. 0.154 H NaCl, 8 ml. 0.154 ~ KCl, 6 ml. 0.110 H 
CaC12 , and 2 ml 0.154 H Mgso4 , and adding 25 ml of phosphate 
buffer prepared by bringing 75 ml. of 0.2 ! NaOH to a pH of 
7.4 with 2 H H3P04 and diluting to 100 ml. with doubly distilled 
water. All solutions were prepared with doubly distilled 
water. 
LABELED CARJON DIOXIDE COLLEQTION AND MJA.SUREMENT 
Radioactive carbon dioxide produced by the oxidation of 
the radioactively labeled substrate in the bone tissue prepara-
tion was absorbed in 0.2 ml of a 10% solution of potassium 
hydroxide contained in the centerwell of the incubation flask. 
The centerwell of the flask also contained a small fold of 
37. 
Whata\an 11 filter paper. The purpose of the paper was to 
increase the surface area of contact of the potassium hydroxide 
solutioa and to help control mov.aent of the liquid durin& the 
incubation in. the abakar bath. 
After the incubation period, the filter paper in the 
centerwell waa tran.aferred to a teat tube. Five al of COl free 
distilled water waa added to each tube, aad the contents of the 
tubes were transferred quantitatively to another set of culture 
tubes which each coatained S al of lot. bariua chloride 
solution. The tubes were allowed to stand at room t•perature 
until the white, floeky, precipitate settled. 
The tube conten.ta were transferred into a Tracerlab 
precipitation Apparatus, Model E•ll whlch was fitted with a disk 
of Whatman #SO filter paper. Suction. waa applied an.d the 
radioactive barium earboll&te was plated on the disk of filter 
paper. The plated preoipitate was washed aueceaaively with 
water an.d dried with acetone. The plated aa.plea were allowed 
to dry for two hours before weiahiD& and eounting. 
The coun.tina waa acccmpliahed with a thin end•Vin.dow type 
aaaaably consisting of a Tracerlab Tracermatic SC-83 Scaler, 
Tracerlab SC-100 Multi•Matic Sample Changer, and a Tracerlab 
sc-66 Printing Timer. Corrections for self-absorption (2S) 
were determined by eatabliahina a aa14co3 aelf•abaorption 
curve (Figure 2). The t:abulated data for the determination 
curve appears in Table 11. 
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TABLE 11 
Ba14co3 SELF-ABSORPTION CORRECTION VALUES 
Correction 
1.00 
0.95 
0.93 
0.91 
0.89 
0.88 
0.36 
0.82 
0.80 
0.78 
0.76 
0.74 
0.73 
0.71 
0.70 
0.68 
0.67 
0.66 
0.65 
0.64 
0.62 
0.61 
0.60 
0.58 
0.57 
0.56 
0.55 
0.53 
14.0-14.5 
14.5-1.5.0 
15.0-15.5 
15.5-16.0 
16.0-16.5 
16.5-17.0 
17.0-17.5 
17.5-18.0 
18.0-18.5 
18.5-19.0 
19.0-19.5 
19.5-20.0 
20.0-20.5 
20.5-21.0 
21.0-21.5 
21.5-22.0 
22.0-22.5 
22.5-23.0 
23.0-23.5 
23.5-24.0 
24.0-24.5 
24.5-25.0 
30.0 
35.0 
40.0 
45.0 
so.o 
Correction 
0.52 
0.51 
0.50 
0.49 
0.48 
0.47 
0.46 
0.45 
0.44 
0.43 
0.43 
0.42 
0.42 
0.41 
0.41 
0.40 
0.39 
0.39 
0.38 
0.38 
0.37 
0.37 
0.32 
0.29 
0.26 
0.23 
0.21 
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FIGURE 2 
SELF-ABSORPTION CORRECTION CURVE FOR Ja14co3 
CHAPTER III 
EXPERIMENTAL RESULTS 
The experimets utiliZed the detection of 14c~ evolution 
fram the radioactively labeled substrate as a aeasure of the 
!a yitro oxidation of aubstrate by bone tissue preparations. 
The substrates ueed in the exper~enta included citrate-I,s-14c, 
sueet..nate-2 •,_14c, 2-oxoslutarat .. s-14c. and pyruvate·2·14c. 
The oxidation of these substrates was atuctiecl using frapenta 
aDd MADP fortified hamogenates prepared from the diaphysis and 
epiphysis of f.aurs exclaecl from the various teat animals. 
The data an presented for each flask used in the 
incubation aerlea. The parathyroid atatua of the experimental 
and control animals was assessed on the basis of their 
respective aerua calcium levala. The blood aamplea were 
obtained immediately prior to sacrifice and analyzed later for 
calcita concentration. The elapsed tinle between sacrifice of 
the anlaals and the beainnlna of the experbumt ruaed from 
2 • 3 hours • durba wbich time the tissue was prepared for 
incubation. 
lm>tr!Un$ 1 ' Tbt lncub!ti9D o( ram•!• 2f [ENE Pl•Rh'ttt.• 
apd IRJ.RhYtil PDRH:fd frc;g fiE-IEftted M4 CptJ'ol Agi.malt 
!ita CJ.tr•tt:l.-s14Q. 
Slx thyroparathyroldectaaized rata were used ln the 
experiment. Three of the six were injected subcutaneously with 
parathyroid extract and three with vehicle. Tbe rata which 
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received 150 u.s.P. over. a period of two days showed an averase 
increase in serum calcium of 2.9 mg%. 
In the experimezat, 1.0 mt.crocurie of radi.oaetive sub-
strate, 150 .. 200 ma of bone frapents aDd 4.0 ml of t.ncu.batiOJ'l 
media were present in eaeh t lask. The incubation was carried 
out for two hours at 37° c. 
The results of the experiment appear in Table 111. The 
diaphysis of the femur showed a depreasion in the oxidation of 
substrate by the bone preparation obtained fram the PTE-treated 
animals. The epiphysis of the f..ur exhibited an increase in 
the oxidation of the radioactive substrate by the bone 
preparations obtained from the PTE-treated animals. 
E2SJ?eriJe&t 2; tht lgcy,b,asion tf ,F;apaJ!.t• Stf Fsur Diaphrsis 
and Epiphysis fr:c:p fiE·Tnatn •14 Coptrol A;imala with 
susslnett·2.l-14c, 
Biabt thyroparathyroideetomized animals were used in 
Experiment 2. Four of the rats reoei ved subcutaneous injections 
of 150 u.s.P. units of parathyroid extract over a period of two 
days. The control antmala received a comparable injection of 
vehicle. The PTE-treated an~als had an average increase in 
serum calcium of 2.7 ·~· 
Two mierocurt.es of auccinate-2.3-14c, 200 ma of bone 
fragments and 4. 0 ml of incubation media were present in each 
of the incubation flasks. The incubation was run for three and 
one-half hours at 37° C in a constant te:aperature shaker water 
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TABLE 11! 
LABELED CARBON DIOXIDE PRODUCED FROM THE OXI~TlON OF 
CITRATE•l,S-14c BY FAAGMENTS or FEMUR DIAPHYSIS AND EPIPHYSIS 
DlAPJIYS:tS 
Experimental Aetivity 
S!!bllE•!I Qsmsti:tig 's:•lu bene l 
Citrat:e-1,.5-14c PTE-Treatment 22 
Cl.trate-1,s-14c PTI•Treataeat 31 
14 Citrate-1,.5- C Ccmtrol S2 
14 Citrate•l,S. C Control 49 
EPIWJ§lS 
Experillleatal Activity 
~!ab&UiE•!i! Condition ~smlm& bone} 
14 Citrate-1,.5- C PTE•Treattnent 19 
Citrate-l.s-14c PTE-Treatment 23 
14 Citr.ate-1,5- C Control 13 
Citrate-l,s-14c Control 10 
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bath. 
The diapb¥sis of the femur showed a depression in the 
oxidation of substrate by the bone preparation obtained from the 
PTE-treated animals when CGalpared to that of ccmtrol anltaals. 
The epiphysis of the faaur produced an increase in the oxidation 
of the radioactive substrate by the bone preparation obta1Ded 
fr• tbe PTE-treated animals (Table lV). 
!xptJ1RW 3: TM INN12!tlop of fiiPMtf gf l'lfiNt D1aphxs1s 
ap4 Ea1pbra1t PrtRff!d (tl! ETI-Treattf apct C!ft;rol An11fl• 
with PJrul!tt:2-14g. 
SS.x thyro,aratbyroidecta.i&ed rats were uaed in the 
experlaeat. Three of the aalaals were injected subcutaneously 
with 150 u.s.P. units of paJ:athyrOid atn.et and three were 
injected subcutaneously with ~icle over a period of two days, 
The rata which were injeatecl with parathyroid extract showed an 
averaae increase in serua caleiua of 2,8 •a~. 
Two mic:roc:uries of ractioacti ve substrate, 100 •1 of bODe 
frapenta, and 4,0 ml of media wen present ira each incubation 
flask. The incubation was performed for three hours at 37° c. 
It can be seen from the data preaented in Table V that 
the diaphysis of the femur showed an inereaae in the evolution 
of 14co2 by the bone preparation obtained from the PTE-treated 
antmals, The epiphysis also showed an increase in the evolution 
of 14c~ from the radioactive substrate by the bone preparatioa 
obtained from the PTE-treated antaals. 
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TABLE IV 
LABELED CARBON DIOXIDE PRODUCED PROM THE OXIDATION OF 
SUCCINATI•2,3-14c BY FRAGMENTS OF FEMUR DIAPHYSIS AND EPIPHYSIS 
RlAPHJSlS 
Sub! tEAS! 
Suecinate-2,3-14c 
Suecinate•2,3-14c 
Succ1nate-2,3-14c 
Suocinate•2,3-14c 
Succinate-2,3-14c 
Sucolnate-2,3-14c 
EPIPHXSIS 
IQ1$EIII 
Succ:laate-2,3-14c 
Suc:einate-2,3-14c 
Suec:inate-2,3-14c 
Suoe1nate-2 1 3·14c 
Suoelnate-2,3-14c 
Suooinate-2,3-14c 
Exper:laeatal 
QoMitiop 
l'TI•Tr:eatment 
PTE-Treatment 
PTE•Treat:aent 
Control 
Control 
Control 
Experimental 
COftdL$1:19 
PTE•Treatatent 
PTE·Tr:eatiMftt 
PTE· Treatment 
C011trol 
Control 
Control 
Activity 
< £111/m' bont) 
29 
30 
31 
48 
44 
38 
Activity 
<cnalraa ,., > 
88 
71 
72 
53 
'' ss 
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TABLE V 
~~~~!~!~~,~~ ~~O~~~~~~ug~B~~D~~~~i~!~~NE;iPHYSlS 
DIAPHYSIS 
Subatr•$1 
Pyruvate-2-14c 
Pys'UV&te-2-14c 
Pyru.vate-2-14c 
Pyruvate-2-14c 
Pyruvate-2-14c 
Pyruvate-2-14c 
Sybstrate 
Pyruvate-2-14c 
Pyruvate-2-14c 
Pyruvate-2-14c 
Pyruvate-2-14c 
Pyruvate-2-14c 
Pyruvate-2-14c 
Exf.ierimental 
Condit ism 
PTE-Treatment 
PTE-Treatment 
Control 
Control 
Control 
Experimental 
ggmtitiop 
PTE-Treatment 
PTE-Treatment 
PTE-Treatment 
Control 
Control 
Ccmtrol 
Activity 
'epmlms bone) 
382 
370 
367 
264 
222 
203 
Activity (cme/•s bone) 
780 
800 
920 
.564 
574 
610 
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Boae cella are diat:ribut:ec.t unevenly t:hroupo.t: the bone 
tiaaue. Oaeification centers and arowina areas of bone will 
have a deaser cell populatioft tban older, completely mineral· 
ize4 areas of bone. In the preparation of bone frapente the 
poaeibility exists of inadvertently "loadina" an incu.bation 
flask with tissue containin& a preponderance of living cells 
and another with tiaaue containina mainly non-viable material. 
Also, the radioisotope must penetrate the intricate canals in 
the fragmentized Haversian system of the f.-ur in order to come 
into contact with the viable cell. This means that production 
14 
of COa from labeled substrate vill at least partially reflect 
the ability of the labeled aubstrate to penetrate into the cell. 
Thus a method vaa devised to obtain a more physically 
uniform bone preparatiOD with the use of a bone diaintesrinder 
( Kontes).. The homoaenate prepared throuah the uae of the 
disintearinder was rather coarse and bad to be kept agitated or 
the mil~ auapenaion would rapidly settle out. To measure the 
homoaeneity in the various homoseaatea prepared, one ml aliquot& 
were pipetted into preweiabed planchet• alld dried. The dried 
aliquot• had a vei&ht variation of ! 0.20 m& in lS ma, the wei&ht 
of a 1 ml aliquot. 
47. 
gxperlmgta 4 aDd 5: The Ingubation ot !Jomosenates of Iemur 
D\aphyeis and En!Rbf•l• Prepared from PTE-Treatt,d and Contro~ 
~nimals wi~h.gitr~te-1&~-~4c, 
Four thyroparathyroideetamized rate were used in eaeh 
experiment. Two rats were injected aubeutaneously vi th 
parathyroid extract and the control antmals were injected with 
vehicle. The animals which reeeived 162 u.s.P. units of para• 
thyroid extract over a period of two days showed an average 
inerease tn serum calcium of 2.1 tDg% in Experiment 4 and 2.4 mg,. 
in Expertment S. 
In !xperi.ment 4, 0.5 mieroc:urie nf radioactive substrate 
e.nd 4 .. 0 ml of homogenate were present in each flask. The 
ineubati«m was run for thr4'tf! hours at 37° c .. 
Femur diaphysis and epiphyais showed no differences in the 
oxidation of .ubstrate by bone preparations obtained from the 
PTE-treated rats when camparfl!d to that of control preparaticma .. 
(Table VI). 
In Experiment S, one microcurie of cltrate-1,5-14c and 4.0 
ml of bone homogenate were present in each ineubation flask. 
The lneubat:1.on was performed for three hours at 37° C in a 
eortstant temperature shaker water bath. 
Femur diaphysis and epiphya1a showed no differences in the 
oxidation of aubstrate by bone preparation obtained from the 
PTE•treated animals when compared to that of control preparations 
(Table VII). 
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TABLE VI 
LABELED CARBO~ DIOXIDE PRODUCED FRQvi THE OXlDATHiN Or" 
CITRATE·l,S-1 C BY HOHOGERATES OF FEMUR DIAPHYSIS AND EPIPHYSIS 
PlhfHX§I§ 
Suhftrate 
Citrate-l,s-14c 
Citr.ata-1,5-14c 
Citrate-1,5-14c 
Cl.t:rata-l,s-14c 
PiPlP}JXSl§ 
SJJJ!IS£•tl 
Cltrate-1,.5-14c 
C1trate-l,s-14c 
14 Citrate-l,S· C 
14 Citrate-l,S- C 
Experiaeatal 
ConditiOJj 
?TJ:!:-Treatment: 
PTE-Traatment: 
Control 
Control 
Experimental 
sta~&!&!l 
PTE-Traatlaeat 
PTE-Treatment 
Control 
Control 
Activity 
( qpa/m& bon•) 
45 
43 
41 
Activity 
'•waa J2onel 
64 
67 
65 
63 
49 .. 
TABLE VII 
LABELED CARifl DIOXIDE P&OOUCED FROM THE OXIDATION OF 
CITRATE•l 1S• C BY HOMOGIIATES OF FEMUR DIAPHYSIS AND EPIPHYSIS 
DJAPHJSIS 
Subttrttt 
Citnte-t,s-14c 
Citr:ate-t,s-14c 
Citrate-t,s-14c 
C1trate-t,s-14c 
EPlPHJSJS 
S\IJa•tntt 
Ct.trate-l,s-14c 
Citrate-t,s-14c 
C1trate-t,s-14c 
Citrata-t.s-14c 
Experimental 
Cta41S\• 
PTE·Tnatmeat 
COiltrol 
COI'ltrol 
lxperi.aeatal 
ga•a:s\a 
PTE•TrMtment 
PTE•Treatlltmt 
Coatrol 
Control 
Activity 
(qa£raa bsms) 
26 
22 
22 
24 
Aoti'rity 
hnalu boa l 
36 
34 
34 
33 
so. 
Eperiatpt 6: Tbt lgsubation of Homoaenatt• of Feu£ DiaRhYaip 
!Q!I lpipbr!\1 PrtHnf fng PTE•Tre&ted &M Ct!t£01 Agimtll 
14 
with Sgscinate-2,3- c, 
Four tbyroparathyroideetomi&ed rata vere uaed in the 
experiaent. Two of the rata were 1ajected aubc:utaneoualy with 
parathyroid extract and two were iajected with vehicle over a 
period of two days. The animals which each noelwd 162 u.s.P. 
units of parathyroid extract d .. onl'trate4 an averaae increase 
in aerua calcium of 2.9 a&%. 
One half microcurie of radioactive substrate and 4.0 ml of 
hoaogenate were present in aac:h flask. The incubatioa was run 
for three houre at 37° c. 
14 No differeacea ia the evolutioa of co2 vere noted iD 
either the diap~aia or the epiphysis prepared either from 
PTE•treated and coatrol ant-ala (Table Vlli). 
lxaerlaat l M4 8; Tat IDGHiiH !( fJOIIUM!tts of FEN£ 
Pi•Pb't•il aa• bipbytif lDMEft ,,. PII yd COgt£01 AglMll 
!i~b frrvl!!t=2-14g, 
Four thT£0Paratbyroideetoaized rata were used in each 
experiment. Tvo of the animals were injected subcutaneously 
vitb parathyroid extract and two were injected with vehicle over 
a period of two days. The rats which received 162 u.s.P. units 
of parathyroid extract showed an averaae increase in serum 
calcium of 1.8 •s" in Experllaent 7 aDd 2.S ma" in Experlment 8. 
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TABLE VIII 
~~~i~T~~!~t£~O~iD~~~~~~~S~~F~RO~~~~~sO:No EPIPHYSIS 
DIAPHISlS 
Sybstratt 
Sueeinate-2,3-14c 
Suecinate-2,3-14c 
Succinate-2 1 3-14c 
Succinate-2 1 3•14c 
Succ1nate-2 1 3-14c 
Suceinate•2 1 3-14c 
Succinate-2,3-14c 
Succinate-2,3-14c 
EPlPif(SlS 
Sul»etrttt 
Sueeinate•2 13-14c 
Suee1nate-2,3-14c 
Suec1nate-2,3-14c 
Succ1nate-2,l-14c 
14 Suceinate-2,3- C 
Succinate-2 1 3-14c 
Succ1nate-2,3-14c 
Suce1nate-2 1 3-
14c 
Experiaumtal 
Qoad~tston 
PTE-Treatment 
PTE-Treatment 
PTE-Treataent 
PTE-Treatment 
Control 
Control 
Control 
Control 
E.:xperimenta 1 
CoadlJ:lM 
PTE•Tre&tllltmt 
PTE• Treatment 
PTI•Treatllent 
PTE-Treatment 
Control 
Control 
Control 
Control 
Activity 
'gpmby. b9ftl} 
19 
18 
18 
17 
19 
lS 
17 
19 
Activity 
<male• bsm•> 
ss 
60 
57 
ss 
ss 
53 
56 
S7 
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One-half microcurie of radioactive substrate and 4.0 ml 
of homogenate were present in each flask in Experiment 7. One 
microcurie and the same amount of homogenate were present in 
each flask in Experiment 8. The incubations were carried out 
at 37° C f~r three hours. 
The diaphysis of the femur showed an increase in the 
oxidation of pyruvate-2-14c by bone homog~na~e prepared from the 
PTE-treated animals. The epiphysis of the femur also showed an 
increase in the oxidation of substrate by bone prepared from the 
PTE-treated preparations. This pattern was observed in both 
Expertments 7 and 8 (Table IX and X). 
It is apparent from the results (Experiments 4 - 6) that the 
homogenization procedure has a profound effect on the ability of 
the bone tissue preparation to detect hormonal treatment on a 
metabolic level, as indicated in the absence of alterations in 
the oxidation of organic acid. The preparations were viable in 
that 14co2 was produced from eitrate-t,s-14c and suecinate-2,3-
14c, but no differences could be detected between the PTE• 
treated and control preparations of diaphysis and epiphysis. 
This finding is similar to that reported by Mecca et al. (78) 
in which case homogenized calvaria were viable but showed no 
differences in the oxidation of organic acids when incubated 
with PTE as the tissue did when intact calvaria were incubated 
with PTE. 
However, comparable homogenate preparations incubated with 
TABLE IX 
LAffL!D CARBON DIOXIDE PRODUCED FRQ1 THE OXIDATION OJ! PYRUVATE· 
2· C BY HQ100ENATES Of' FEMUR DIAPHYSIS AND EPIPHYSIS 
DJ.!P!.iX§l§ 
Experimenta 1 Aetivity 
iYJ!IIE•Sil ~Ol'ldii&ID 'CJ!Ilal J!2!!! ~ 
Pyruvate-2-14c PTE-Treatment 780 
Pyruvate-2-14c P'l'E•Treat~aeat 810 
Pyruvate-2-14c PTE-Treatment 960 
Pyr:uvate-2-14c PTE-Treatment 840 
Pyruvate-2-14c Control 570 
Pyruvate-a-14c Coatrol 580 
PyJ:uvate-2-14c Control 580 
Pyruvate-2-14c Control sso 
iP&flii§l§ 
Experimental Activity 
§yb!l£!11 ~21Wi~i2D 'IJBial JIOD!l 
Pyruvate-2-14c PTE-Treatment 1,380 
Pyruvate-2-14c PTE•Treataent 1,400 
14 Pyruvate-2- c PTE•T&"eatmat 1,590 
Pyruvate-2-14c PTE-Treatment 1,390 
14 Pyruvate-2- C Control 1,320 
Pyruvate-2-14c C<mtrol 1,200 
Pyruvata-2-14c Control 1,200 
Pyruvate-2-14c Control 1,300 
54. 
TABI~E X 
LABELED CARBON DIOXIDE PRODUCED FaOM THE OXIDATION OF PYRUVATE• 
2-14c BY HOMOGENATES OF BONE DIAPHYSIS AND EPIPHYSIS 
DlAPH't'S!S 
Substrate 
Pyruvate-2-14c 
Pyruvate-2-14c 
Pyruvate-2-14c 
.Pyruvate-2-14c 
PyJ:Uvate-2 ... 14c 
Pyruvate·2-14c 
gPIPHXSIS 
§yf!!t{&tt 
Pyruvat:e-2-14c 
Pyxuvate-2-14c 
Pyxuvate-2-14c 
Pyruvate-2-14c 
Pyruvate-2-14c 
Pyru.vatt·2-14c 
Experimental 
Conditt on 
PTE-Treatment 
Control 
Control 
Control 
Expertmental 
~!U~~lsm 
PTE•Ts:eatment 
PTE-Treatment 
PTE-Treatment 
Control 
Control 
Control 
Activity 
~ SPmLmg bon!) 
1,220 
1,100 
1,160 
840 
700 
740 
Activity 
LsuaLea bD!l 
3,250 
2,800 
2,900 
2,200 
2,300 
2,300 
ss. 
pyruvate·2-14c were aenaitiv. to preparation difference• in 
hoz:monal treat:meDt (PTE va. c:ontr:ola, Experiment• 7 and 8). 
Mecca et al. found that the addition of the cofactor NADP to 
calvaria haaoaenatea would lnereaae viability of the hoaosenate 
aftd reatore the eenaitivity to PTE-treatment, in the oxidation 
of oitrate-l.s-14c. No other labeled aubatratea except 
c1trate•l,S-14c were uaed in tbia procedure. 
ln the next aerlea of experiaenta, hcaoaeraatea were prepared 
in the uaua l .. aner 1 except that a meaaured aount of NADP waa 
added to eaeb h•oaenate. Thia proeedure waa decided upon to 
determine if the addition of thie cofactor to femur homoaenate 
would reatore viability and/or aenaitlvlty of the bone prepara-
tion to PTE•tre&taent. 
EutmtH 9! 1bt IgCN\WliOD of !f.DP t:utt.fitsl Hsaosgate• of 
fWIE DltRhYI\1 u« IRiPbTtil fEtD!rtcl fl!!! fli•IQ!t!d Msl 
x?DtJ'!l AnJ•ll !!J.tb C1mtt::l,S-14$i 1 
Pour thyroparathyroideetcaized rata were uaed ill the 
experiattDt. Two of the ant.mala were injected aubcutaneoualy 
with parathyroid extract and tvo were injected with vehicle. 
The rata vb.1ch received 100 u.s.P. unita of injection parathyroid 
d .. onatrated an a.,.raae lncreaae in aeZ\111 calclu. of 3. 0 •a% 
over the CODtro 1 anilla 11. 
One-half alerocurie of radloaeti,. aubatrate1 4. 0 ml of 
homoaenate and 16.0 mieramolea of NADP were preaent in each 
f.laak. The ineubation waa carried out for three hours at 37° c. 
56. 
The diaphysis of the femur demonstrated an increase in the 
oxidation of radioactive substrate by bone homogenate obtained 
from PTE-treated animals. The epiphysis of the famu: also 
showed an increase in the oxidation of substrate by bone 
hamoaenate obtained from the PTE-treated anlBals (Table XI). 
Ege@ent \OJ Ib! Jpc;ubatlOJ) q( NADP fs!J;ti(l!d Homogenate& 
of lfiY£ Diaphy1ia agd lpiphts1a PttP!Eta f£08 PTE•Irf!ted apd 
Qoptrol Ani.Ja!l! with Suqs1aftt=2,3-14g, 
Four thyroparathyroideotomized rata were uaed in the 
experiment. Two of the Z'&ta were injected subcutaneously with 
100 u.s.P. units of parathyroid extract; two received a compar-
able volume of vehicle. The animals which received the 
parathyroid injection showed an averaae increase in serum 
calcium of 2.6 mg~. 
One•half microcurie of radioactive substrate, 4.0 ml of 
11omosenate, and 16.0 mlcraaolea of NADP were preset in each 
flask. The incubation wa oanied out for three hours at 37° c. 
The diaphysis of the femur ahowwd an increase in the 
oxidation of the substrate by the bone preparation obtained 
frc:a the PTE-treated animals. The epiphysis of the f•ur 
damonetratad an inereaee in the oxidation of the substrate by 
bone preparations obtained from PTE-treated antaala (Table XII). 
$7. 
TABLE Xl 
LABELED CARBON DIOXIDE PRODUCED FltQf Tmt OXIMTlON OF 
CITRATI•1,5-14c BY HOHOGIMAT!S OF FEMUR DlAPHYSIS AMD EPIPHYSIS 
FORTIFIED WITH NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE 
DJAPijYSI§ 
Experimental Activity 
SuliiiEIII ~,,,. 's•l.ma HI! l 
C1trate-1,5-14c PTI•Tn&ta8Dt 126 
C1trate-t,s-14c PTI•Treataaen.t 123 
C1trate-1,S·.l4c C01ttnl .53 
Ct.trate-1,5-14c Contrel 59 
lflPHXSJS 
Expert.a•tal Activlty 
Sy\t!CFftt C.0 Ddla,i2D '•WBl•& taal 
Citrata-t,s-14c PTE-Treatment 385 
Citrate-t,s-14c PT!·Tnatment 365 
14 Citrate-1,.5- C Control 290 
Citrate-l,s-14c Control 280 
TABLE XII 
LABEfE CARBON DIOXIDE PRODUCED FR<»> THE OXIDATION OF SUCCINATE· 
2,3- C BY HOMOGENATES OP FEMUR DtAPHYSIS AND EPIPHYSIS 
FORTIFIED WITH MICOTIIAMIDE ADEIIftl DIKUCLIOTIDI PHOSPHATE 
QIAfliXIll 
§ybttE•l.t 
Suce1nate-2,3-14c 
Suceinate-2,3·14c 
Suecinate-2,3-14c 
Succlnate-2,3-14c 
J;PlPlfiSJS 
§»bttDtl 
Succinate-2 1l·l4c 
Succiaate-2,3·14c 
Suacinate-2,3-14c 
Suae1nate-2,3-14c 
Eapert.a•tal 
Condit!sm 
PTE-Treatment 
PTE-Treatment 
Cntrol 
Coatrol 
Experimental 
Coa4itlon 
Control 
Control 
Activity 
(.;a/m~ b9!J!l 
1,280 
1,120 
870 
910 
Aetivt.ty 
'mal•& bgu} 
2,540 
2,4.50 
1,830 
2,140 
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IXH£t.uns II; Tbt &P&ba~icm of MDP Fortified Homoaetea of 
I:M\11' Qifphyfil 11!4 lpiRhxtl.l P£tR!ted (r99 PTE•Tqab4 and 
Qon;rol AaiMl• ¥ltb Pu.uDSe-2-14c. 
Four thyroparathyroidec:tamizect rata were uaed in the 
experiMent, Two of the rata reeei~ dosea of parathyroid 
extract, and two were injected vt.th vehicle. The rata which 
received 100 U.s. P. uni ta of parathyroid extract d•onatrated 
an averaae increase 1ft aes:um calcium of 2.5 asS over the level 
of the ontrol animals. 
One-half mleroourie of radioactive aubatrata, 4. 0 •1 of 
homoaenate and 16.0 aieramolea of NADP were preaent in each 
flaak. The incubation waa carried out at 37° C for three houra. 
The diapbyaia of tba feaur ahowad aa inoreaae in the 
oxidation of subatrate ~ tbe bone homoaenate obtained fram the 
PTE-treated anilaala when c•pared to tbat of the control 
antaala. The epipbyaia of the femur d .. onatrated an increase ln 
the oxidation of the radioactive aubatrate by bone hamogenate 
obtained from the PTE-treated an~la (Table XIII). 
Exper~enta 9 • 11 indicate that the addition of NADP ia 
effective ln reatorlna viability to the bone preparation•. 
Femur prepared •• NADP fortified bomoaenatea oxidizea citrate-
t,s-14c, suecinate-2,3-14c and pyruvate-2-14c at a greater rate 
than control preparations ln both diapbyaia and epipbyaia. In 
the caae of the epipbTaia tia.ue, this ia the aaae pattern of 
oxidation which waa obaerved uain& bone frapenta (Experiments 
60. 
TABLE Xlll 
LAf!LED CARBON DIOXIDE PRODUCED FROM THE OXIDATION OF PYRUVATE-
2· 4c BY BONE HOMOGENAT!S OF FEMUR DIAPHYSIS AND EPIPHYSIS 
FORTIFIED WITH NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE 
Substrste 
Pyruvate-2-14c 
Pyruvate-2-14c 
§:fiPHYSJS 
§HJ!It&•t! 
14 Pyruvate-2.. C 
Pyruvate-2-14c 
14 Pyruw.te-2• C 
14 Pyru'V'ate-2- C 
Experimerttal 
C2Pdi ~i ... C!ft_ 
PTE-Treatment 
PTE-Treatment 
Control 
Ccmtrol 
!xperimenta 1 
S&ond!~J:on 
PTE-Treatment 
PTE-Treatment 
Control 
Control 
Activity (.£m/ms bontl 
276 
261 
202 
215 
Aeti'Vity 
!sml•s Jl2n1l 
650 
678 
383 
373 
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1 - 3). However, the pattern of oxidation in the hamoaenatea 
of the diaphysis is different from the pattern observed using 
homogenate& of the epiphysis. The rationale for this difference 
will be discussed in detail in Chapter IV. 
It now appears that bone prepared aa NADP fortified 
hamogenatea from PTE-treated antmala will metabolize Kreba cycle 
and alyeolytlc intermediates at a greater rate than do control 
preparation. Concomitant with increased metabolic rates, PTE-
treated animals have increased levels of serum calcium. lt has 
yet to be established whether the increased rate of metabolism 
due to injection of PTE ia instrumental in atilllulatina increased 
levels of serum calcium or whether elevated levels of serum 
calcium caused by the injection of PTE are instrumental in 
increaain& rate of metabolism. 
In explorlna the latter poatulate 1 the following aeries of 
experiments were desipe<l to study the !a ntro and in .!!.:!.!! 
effect of calcium ion concentration with no hormonal treatment 
on bone metabolism. 
bJ>er1Jatnt 12: Tbt Incubata.on of NADP Fortlfa.ld HC!!oaenatea of 
Vfrla,te Calglum 109 QonsenSretlon Prtpar!d frga ft~ur D\apbysla 
and lpiphyala of Noraal Aa&mala !ith PJIYVate·2-14c, 
Slx normal animals were selected for the experiment. The 
f•urs from these anlmala were prepared in the usual fashion 
except that the femur diaphysis and epiphysis from the three 
pairs of animals were homoaenlzed in incubation media containing 
62. 
6 m&% 1 10 mgJ. and 14 mg% ealeium respeetively. 
One-half microcurie of radioactive substrate, 4. 0 ml of 
homogenate and 16.0 micromolet of NADP vere present in each 
0 flask. The ineubatlon vas can:iec:l out at 37 C for three hours. 
The mapltude of evolutlOD of 14c~ appeared to parallel 
the mapitucle of calcium. ion pretent in the medium of both 
haaosenatea of diaphysis and epiphysis (Table XIV). Aa the 
calcium of the medium was lnereased from 6 ma,. to 14 mg1., the 
14 total aaount of evolved co2 vas increased. 
hptrimenS Jl; fbt lDeub,aS12!l tf MDP Futifi§ B9!Pot;enatea 
fE!R!rtd frgp FI!Y£ DitRbZill !ad Ep\phfait of Ag~lt Mt1Q• 
tatgtd op NO!!fl pnd Ca&c~·dtficlent Diet• with Py;uJ!tt=2-14c, 
Of the four th)'roparathyroideetomlztd ard.mala selected for 
the experl.aent, two were aaintal.Dect em a ealclum•deficleat teat 
diet (Nutritional Biochemical Corp.) artd two were aud.ntalned on 
a normal diet for a. period of one week. Serum calcium concen-
trations for the calcium-deficient and normal diet anilaals 
averased s.s m.s~ • 10.6 ma% respectively. 
One•half alcroeurie of radioactive substrate, 4. 0 mls. of 
hCIIaogenate and 16.0 micrOJDoles of IADP were present in each 
flatk. The incubation was carried out at 37° c for three hours. 
lone epiphysis and diaph)"ats prepared from uimala main-
tained on a calct.um-deficlent diet produced leas 14c~ frcm the 
substrate than did thoae bone preparations obtained from 
animals maintained on a normal diet (Table XV). 
TABLE XIV 63. 
LABELED CARBON DIOXIDE PRODUCED FROM THE OXI~TION OF 
PYRUVATE·2-14c BY HOMOGENATES OF FEMUR DtAPHYSIS AND EPIPHYSIS 
FORTIFIED \HTH NICOTINAMIDE AlJENl.~H~ DlNUCLEOTlDE PHOSPH'1-TE AND 
CONTAINING A VARYING AMOUNT OF ~LClUM ION. 
DIAPHYSiS Experimental Activity 
§ubs~[a~e gousU.stsm '~i!!lm& 22!1!l 
Pyruvate-2-14c 6 ma7. Calcium 72 
Pyruvate-2-14c 6 sqf. Calcium 80 
Pyruvate·2-14c 6 me'- Calcba 99 
Pyruvate·2-14c 1 o aa7. ca lcb• 136 
Pyruvate-2-14c 10 •a% Calet.Ulll 118 
Pyruvate-2-14c 1 0 qt. Calct.um 139 
14 Pyruvate-2- C 14 ma7. Caleba 17.5 
Pyruvate·2-14c 14 •&'- Calcium 168 
Pyruvate-2-14c 14 ma~ Cal.ct.ua 172 
e~:=;~ Experimental Activity ~IJ!d1S19J! 'sal• l!aosl 
Pyruvate-2-14c 6 ma" Calct.um 207 
Pyruvate·2-14c 6 ma1. Caleb• 206 
Pyruvate-2-14c 6 ma., Calcba 218 
Pyruvate-2-14c 1 0 ma% Ca lciUID 283 
14 Pyruvate-2- C 10 mat. Calct.um 29.5 
Pyruvate-2-14c 1 0 mg'J. Ca. lebam 310 
Pyruvate-2-14c 14 •a' Calcium 3.54 
Pyruvate·2-14c 14 ma1. Calet• 360 
Pyruvate-2-14c 14 qf. ea lcb• 347 
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TABLE XV 
LABELED CARBON DIOXIDE PRODUCED FRCI'l THE OXIM.TION OF 
PYRUVATE•2~14c BY HOHOGENATES OF FIMUR DtAPHYSIS AND EPIPHYSIS 
!'ORTlFIED WITH NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPW.TE AND 
PREPARED FROM ANIMALS ON CALCIUM•DEPlCIEMT AND NORMAL DIETS 
DlAPHY§I§ 
§ubatas• 
Pyruvate-2-14c 
Pyruvate-2-14c 
Pyruvate-2-14c 
Pyruvate-2-14c 
Pyruvate-2-14c 
Pyruvate-2-14c 
CfiP§XSIS 
Sub&S£&t! 
Pyruvate-2-14c 
Pyru.vate·2-14c 
Pyruvate-2-14c 
Pyruvate·2-14c 
Pyruvata-2-14c 
Pyruvate·2-14c 
Experbumtal 
!itMiSioa 
Serum Calcium 
{ma1,} 
Calcium Deficient 8.8 
Calcium Deficient 8.3 
Calcium Deficient 
Nor:mal 
Noxmal 
Nor:mal 
8.4 
10.6 
10.3 
10.9 
ExperiraMta l SU'UlB calcium 
~lsla 
Calcium Deficient 
Calcium Deficient 
Calcium Deficient 
NOJ::aal 
Nonaal 
Nonal 
'mdl 
8.8 
8.3 
8.4 
10.6 
10.3 
10.9 
Activity 
''*"' bO!)f l 
94 
98 
66 
120 
117 
132 
Activity 
'sualu !!Btl 
227 
224 
221 
391 
381 
340 
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Experiments 12 and 13 indicate J.a '!it£! aftd 1!1 l'1:D calcium 
ion conc.atratione prior to aacrifiee can influence bone 
metaboli• 11! Y\Sro• The oxidation pattern presented in the 
data of Experlmellt 12 res .. bles the oxiclative pattem presented 
by the injeeti.on of PTE in that both the injection of PTE and 
hip oOBoentrattons of i!l ntrt c:alolUDl lOll ( 14 ma~) att.mulate 
bone oxidation of substrate, Conversely. bOile preparation 
lru:ubated in low ccmoentratioa of calcium (6 ma1.) or prepared 
from animals maintained on a calcium-deficient diet and bavin& 
low sei'UDl calcium values peaseeeed the least oxidative activity 
in teras of 14c~ evolutiOD, 
To detenlae whether or not the observed oxidative pattern 
is eoneieteat in bona prepared frea aalmale made hypooalc .. t.c 
by injection of TCT • the following aeetioa of experiments was 
deeip.S. 
Jxperlmt!!t 14: Dt IRIUbttlop ot Fraall\!1 li'.IP!Ffd tr• tb! 
twur pt.tplw•t.• amt Mph'''' 9f tqt·Tnet!d !!!d £ontaJ. 
An'lflt !itb Citrttt•1.~14c, 
Four animals were thyroparat~idectoaized and maintained 
oa a aomal diet ad libitum for two days after surgery. Then 
two of the four aniaala received intraperitoneal injections of 
15 ma of thyrocalcitonin Tel powder dlaaolved in 0.01 1 acetic 
aeld ln two doaea of o.s al over a period of two hours. The 
control antm&la reaei ... coaparable injections of 0.01 1 acetic 
aeld. The • ..,_ calcium levels of the TCT•treated and c:o.ntrol 
66. 
artl.mals averaged 9.8 me;% artd 10.0 ma% respectively. 
A weighed quantity (approximately 100 m&) of fl'agment:s of 
femur diaphysis and epiphysis was placed in eaeh flask and to it 
4.0 ml of ineubaticm aedia and one mlcroeurie of radioaet!ve 
substrata was added. The incubation vas carried out at 37° C 
for 3 hours in a ecmstant teperature shaker water bath. 
The labeled carbon dioxide produced frem the substrate by 
bone preparation• frcm the TCT-treated and control animals was 
not different (Table XVI). 
Exptrimens• lS amz 16; tht Incubation of NADP Fottifi~ 
ftgmosenates of Ff!Ur PitRbx•&• tnd IR\phttil from TCI•Treated ag4 
GO!ltrol An.yala W\t!l CS.trate=1 • .5·14g, 
P'our thyroparathyrol.dectOIDiZed animals were used in these 
experiments. Seveaty•t:wo hours after aurgery two of the four 
anl.mala were injeeeed wit:b 15 aa of t:hyroealcitonia TCA powder 
diaaolvad in 0.01 1 acetic acid in two dosea of 0 • .5 al each 
over a two hour period. The oontr:ol received a ccaparable 
volume of 0. 01 li acetio acid. Serta calclua values of the TCT• 
tl'eated and control animals averaged 8.9 m&!J. and 9.3 ma'J. in 
Exper1Daent 1 S and 8. 6 m&'l and 9. 0 mg'%. in Experiment 16. 
The f.un were excised, elunecl and hGmogenized. A 4. 0 
ml aliquot of h011ogenate together with one-half microcurie of 
substrate and 16.0 micraaolea of NADP were present in each flask. 
The ineubation was run at 37° C for three hours in a constant 
tasnperature water bath. 
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TABLE XVl 
LABELED CARB~~ DlOXID! PRODUCED Fl\<M THE OXIDATION CF 
CITRATE•l,S• C BY FRAGMENTS OF FEMUR DIAPHYSIS AND EPIPHYSIS 
FRQ1 TilYROCA.LClTOtUN-TRFATED AND CONTROL AIUMALS. 
PMOOSI§ 
Experimental Serum Calcium Activity 
bbtsu;t ~op4lt19J1 • <•JJ%l (cpm/pt~a bon•l 
Citrate-t,s.14c Tct-Treatment 9.4 41 
Cltrate-t,s-14c TCT•Trea~ent 9.2 38 
Cltrate-l,s-14c Control 10.3 44 
C1trate•l,5-14c Control 9.7 36 
IPJPif'SlS 
Expertaental Seruta calcium Aetivlty 
~Y~I~BI:I g2DdlSi!m '•dl 'crab!& b9J!! l 
Citrate-t,s-14c TCT·Treatment 9.4 140 
14 Citrate•1,5- C TCT-Treatment 9.2 135 
14 Cit:rate-1,5· C Control 10.3 150 
14 Citrate-l,S· C Control 9.7 131 
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The results given in Tables XVII and XVIII indicate that 
TCT•treatment does not affect the evolution of 14c0a from 
labeled substrate by either diapQyais or epiphysis. 
The results of ExPeriments 14 • 16 indicate that the dose 
level of TCT administered to the teat atdaals prod.ueea a very 
slight decrease in s_,_ oalalua ( approxlutely leas than 0. S 
ms~) and bas no pronOUDced effect on the oxidation of substrate 
by bcme. This indicates that TCT itself does not affect 
oxidation of substrates in bone tissue. 
Hypercala .. ic animals are more sensitive to a &iven dose 
level of TCT than are aomoeale .. ic antaals. With this in mind, 
the last aeries of experiaents were dest.ped to produee a 
greater fall in serum caleium per close level of TCT which was 
used pre'ri.oualy. The oxidation of aut»strate by borae was com• 
pared in PTE-treated, PTE·TCT-treatecl aacl control aniaala. The 
dose of TCT wbieh was aclal.nistered to PT&-treatect ani.Jilals 
produeed approximately a 2 ma~ decrease in serum aaleiua. 
~attran.se 17. 11 !!!4 12: thl IpguHJloa at @Di! ron\f&Jtd 
tJMO&WJtt tf font PrfBnst fr- Jht PI.&Rhysil M4 IR1Jb.YIJ.I 
!( W•Trl;ltt41 fTI•Tct•TrttJtd trut Csmtro& Agyalt Bth 
21tratt:laS-14g, 
Six thyroparathyroldeet•ized animals were used la the 
experlllent. Twenty four hour:a after auraery, four of the aix 
aniaala received 100 u.s.P. units each of Injection Parathyroid 
over a period of two days in two doses of SO UBits each. The 
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TABLE XVII 
LABELED CARBfl DIOXIDE PRODUCED FROM THE OXl~TlON OF 
CITIATE•1,S• C BY BOHI HOMOGENATIS OF FEMUR DiAPHYSIS AND 
EPIPHYSIS fORTIFIED WITH NICOTINAMIDE ADBNINE DlNUCLIOTIDE 
PHOSPHATE AND PUPAltED FllC»l THYROCALCITOIUft•TUATED AND COlfTilOL 
ANIMALS 
QJAfHXSI§ 
Experilaental 
IUISr•SI ¥0DCIJ.I&!D 
Citrate•1,5-14c TCT•Tn&tael'lt 
Citrate-1,s-14c TCT•Tn&taeDt 
C1trate-t,s-14c TCT•Treatment 
C1trate-1,s-14c Coatrol 
C1trate-1,s-14c CODtrol 
Cltrate-1,s-14c Coatrol 
lfJPHY§l§ 
EX)Htriael'ltal 
llaltiSEISI ¥asl&sl.a 
Citrate-l,s-14c TCT·Treataent 
14 Citrate-1,5- C TCT·Treatment 
Citrate-t,s-14c TCT-Treatment 
C1trate-1,s-14c Coatrol 
Citrate-1,s-14c Control 
14 Citrate-1,5· C Control 
Sei!'\D Calcium 
i!ldl 
8.7 
8.9 
9.1 
9.2 
9.4 
9.3 
s.,. Caleba 
'all 
8.7 
8.9 
9.1 
9.3 
Activity 
haralma 1t1.11l 
Sl 
49 
so 
48 
52 
ss 
Activity 
'sualu t!atl 
140 
150 
130 
148 
134 
139 
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TABLE XVlll 
LABELED CARBi>l DIOXIDE PRODUCID FR<M THE OXIDATION OF 
ClTRATE-1,5- C BY BONE HCMOGENATES OF FEMUR DIAPHYSIS AND 
EPIPliYSIS FORTIFIED WITH NlCOTl~~IDE ADENINE DINUCLEOTIDE 
PHOSPHATE AND PREPARED FROM THYROCALCITONIN•TREATED AND CONTROL 
ANIMALS 
DIAPHXSU 
Experl.aental Serum Calcium Activity 
Subl~£&$1 ggndj.~i2!l hldl 'smlma b9!1! l 
Citrate-l.s-14c TCT•Tre&tment 8.4 42 
cttrate-1,s-14c TCT-Treataent 8.3 38 
cttrate-l,s-14c TCT-Treatment 9.1 44 
14 Citrate•l,S- C Control 8.8 4S 
Citrate-l,s-14c Control 8.7 44 
Citrate-l,s-14c Control 9.2 47 
gPtPHJ:S\S 
Experimental Serum Calcium Activity 
Sl!lz!S£•t! gonsa&s&a ~mdl ~ SElH l!!Dil 
Citrate-l,s-14c TCT•Treatment 8.4 90 
Citrate-l,s-14c TCT·Treatment 8.3 88 
14 Citrate-l,S· C TC'l'•Treatment 9.1 9S 
Citrate-l,s-14c Control 8.8 91 
14 Citrate•l,S- C Control 8.7 92 
Citrate•l,s-14c Control 9.2 93 
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two control animals reeeived no injt:ction whatever. Twelve 
hours after the last doae of Injection Parathyroid, two of the 
four animals each received IS mg of thyrocalcitonin TCA powder 
dissolved in 0.01 ! acetic acid and administered in the form of 
two injections of one-half ml each over a two hou.r period. 
Serum calcium levels prior to sacrifice in the PTE-treated, PTE-
TCT-treatment aDd control animals are indicated in the Tables 
XIX• XX and XXI. 
Bona hamoganatea were prepared and one-half microcurie of 
IUbatrata was introduced i.Dto each flask aa well aa 4. 0 al of 
bone homogenate and sixteen aicromolea of NADP. The incubation 
was carried out at 37° C for three houra in a constant t•pera• 
ture shaker water bath. 
The reaulta of the three experiments (Tables XIX, XX and 
XXI) indicated that the bona diaphysis aDd epiphysis prepared 
from PTK•treated anlatala proclucea a areatar amOUDt of 14c~ 
from substrata than does bone diaphysis an4 epiphysis prepared 
fran PTE•TCT-treated animals. Produc:tlot'l of 14co2 from sub-
st:ratEJ in the bone preparation fram PTE·TCT-treated animals ia 
greater than that produced fran the control animals. 
IXJ?trimet 2Q; Tht Ipcubttlga 9( MPP rgns.t&:tcl uwosaat•• g( 
Bone P£tpareg frqp thg Diaphyfi' fRd Eptehytia o( fii•Treatld. 
PTE·TCT•IreatE apd Cogtnl Aglm!lt !d,tl} §ygc;1Dftt=2 1 3-14q, 
Six thyroparathyroidectomized anill&la were used in the 
axperiaea.t. Twenty four houn after aura•ry• four of the six 
TABLE XIX 72. 
EFFECT OF PARATHYROID EXTRACT ALOME AND PARATHYROID EXTRACT 
TOGETHER. WITH THYROCALCITONIN IN Vl VO ON THE lABEL~ CARBON 
DIOXIDE PRODUCED FR.CM THE OXIDATION OF CITRATE-1 1 .5- 4c BY HOMOGINATES OF FIHUR DtAPHYSIS AND EPIPHYSIS PORTlPIED WITH 
NICOTINAMIDE ADENINE DUWCLEOTIDE PHOSPHATE 
!UAI:Itll§ Ex~imellt:al Set:'\Ul\ Calcium Activity 
llal!IS:,.£1 C2!11!S19.9 .~m!1.l 'SJlm.lms. .. bone l 
Cltrate-t,s-14c PTE 13.5 99 
14 Ct.trate-t,s- c PTE 13.2 98 
14 Citrate-1,.5· C PT! 13.6 103 
14 Citrat:.-1 1 .5- C PTE•TC'r 10.7 sa 
Cltrat.-1,.5·14c PTE•TCT 11.2 .56 
Cit~rate-l,S·14c PTE•TCT 11.2 ss 
Cltrat.-1,5-14c Coatnl 9.8 20 
C1trate-1,.5·14c Control 9.8 19 
Cltrat.-1,5·14c Control 10.2 19 
ll!lEIJISI§ Experiaental Seruat Celoba Activity 
IY!liiE!!il Clll!llSl:lll '!!dl 'SRmbDI b!Ul 
Citr:ate-1,.5·14c PTE 13.5 190 
Clt~rate-t,s-14c PTE 13.2 182 
Citrate-t,s-14c PTE 13.2 174 
Citrate-! ,s • .l4c PTE•TCT 10.7 119 
Cltrate•l,S-14c PT!·TCT 11.2 131 
ct.trat.-1,s-14c PTE,-TCT 11.2 134 
14 Cltrate-1 1 .5- C Control 9.8 82 
C1trate-t,s-14c Coatrol 9.8 16 
Ct.trate-l,s-14c Ccmtr:ol 10.2 70 
TABLE XX 73. 
EFFECT Of PABATHYI.OID EXTI.ACT ALONE AND PARATHYitOlD EXTMCT 
TOGETHER WITH THYROCALCITORUf ott .!1.!.2 ON THE LABEL~ CARBON 
DIOXIDE PRODUCED FROM THE OXl TlON OF CITRATE•1,5· 4c BY 
HOHOGIMATES OF FEMUR DIAPHYSIS AND EPIPHYSIS FORTIFIED WITH 
NICOTlftAMIDI AD!NlNI DlftUCLEOTlDE PHOSP~TI 
I!IAPUI§il !xperiaental Sel.'\llll C& leb.- Aetlvity 
SJ!J!!IE!II C!J!d&li!D 'ull 'SR!!llll ~-ll 
14 Citrate-1 15- C PTE 14.0 106 
Cltt:ate-1,5-14c PTE 13.7 99 
Citrate-1,s-14c PTI 13.1 116 
C1trate-1,s-14c PTI•TCT 11.6 91 
Citrate-1,s-14c PTI•TCT 11.4 85 
Citrate-1,s-14c PTE•TCT 11.5 83 
Cltrate-1,s-14c Coatrol 9.8 52 
C1crate•1 1 .5·14c Coatrol 9.6 .52 
14 Cltrate-1,5· C Control 9.7 66 
~== Expertaeatal Serum C& leba Activity C'DSfll&ll '•dl '••lu J!&ll 
Cltrate-1,s-14c PTE 14.0 404 
Cltrate-1,.5-14c PTE 13.7 450 
Cltrate-1,5-14c PTE 13.8 380 
14 Citrate•l,S· C PTI•TCT 11.6 25.5 
Citrate-t,s-14c PTE•TCT 11.4 262 
14 Citrate-1,.5· C PTE•TCT 11 • .5 271 
Cltrate-t,s-14c Control 9.8 230 
14 Cit:rate-1 1 .5· C Control 9.6 21.5 
Cltrate-1,s-14c Control 9.7 235 
TABLE XXI 74. 
EFFECT OF PARATHYROID EXTRACT ALONE AND PARATHYROID EXTRACT 
TOGETHER WITH THYROCALCITONIN lJ! RON THE LABEL~4 CARBON 
DIOXIDE PRODUCED FROM THE OXI~TIOR CITRATE-1,5- C BY 
HOKOGENATES OP FEMUR DLAPHYSlS AND EPIPHYSIS FORTIFIED WITH 
NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE 
DIAP!!IS&S Experimental Serum ca lc:ium Activity 
1\!lit•!U!I ~2!!!\l.Sigg ~!ldl 's•lu llo!!! l 
Citrate•1,5-14c PTE 13.1 274 
14 Citrate-1,5- C PTE 12.9 2S4 
C1trate-1,S-14c PTE 13.2 265 
14 Cltrata-1,5- C FTE•TCT 11.1 200 
Citrate-1,s-14c PTE•TCT 10.9 192 
C1trate-1,s-14c PTE•TCT 10.8 197 
14 Citrate-1,5- C Control 9.2 197 
14 Citrate-1,5- C Control 9.4 189 
Citrate-l,s-14c Control 9.1 212 
~P&P!!XS&S Experimental Serum Calcium Activity 
SJ!ll!!E8 b ~-di!12!! .~mdl ,&!111!11 bQDil 
Cltrate-t,s-14c PTE 13.1 sso 
Cltrate-l,s-14c PTE 12.9 S10 
14 Cltrate-1,5- C PTI 13.2 S6S 
14 Citrate-1,5- C PTE-TCT 11.1 458 
Citrate-1,s-14c PTE-TCT 10.9 421 
14 Citrate•1,S· C PTE·TCT 10.8 436 
Citrate•l,S-14c Control 9.2 420 
Citrate-t,s-14c COI'ltrol 9.4 470 
Citrate•t,s-14c Control 9.1 439 
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antmala received 100 u.s.P. unite each of Injection Parathyroid 
over a pel"iod of two days ln two ctoaea of SO unite each. The 
two control animals received no injections. Twelve houra after 
the laat doae of Injection Parathyroid, two of the four antaala 
each received 15 •a of thyrocalcitonin TCA powder wbich waa 
diaaolvad in 0.01 ! acetic acid and adainiatered in the for,a of 
two inject lone of one•half al each over a tvo hour period. 
Serum caloiua levels prior to sacrifice in the PTE-treated, 
PTE-TCT-treatmeat and control anlmals averaaecl are illdieatect in 
Table XXII. 
loae h•oaenatea were prepared aDd one-half microcurie of 
substrate vaa iatroducect into each f laalt aa vall ae 4. 0 al of 
bone homosenate and aixteen aicroaolea of ~DP. The incubation 
waa carried out at 37° C for three houn in a conatant t•per• 
ature shaker water bath. 
As ahowa in Table XXII the results of the experiment 
indicate that the bone prepared froa PTE•treated aaiaala produces 
a sreatel:' amaunt of 14co2 fi:'OIIl subatrate, than doee bone 
prepared frG!l PTE-TCT•tr:eated aniuls. Production of 14c<>a frcm 
eubatrate in bone prepared frca PTE-TCT•treated antmala ia 
greater than tbat produced from cumtrols. Thia pattern ia 
observed in the preparations of both the diapbyaia and epipbyaia. 
TABLE XXII • 
EFFECT OF PARATHYROID EXTRACT AI .. oru:: AND PARATHYROID EXTRACT 
TOGETHER WITH THYROCALCITONIN lfi Ill'.Q ON THE LABELED ~RBON 
DIOXIDE PRODUCED FROM THE OXIDATION OF SUCClNATE-2,3- C BY 
HOMOGENATES OF FEMUR DIAPHYSIS AND EPIPHYSIS FORTIFIED WITH 
NICOTINAMIDE ADENINE DINUCLEOTIDE ~tOSPHATE 
DJ!PJ.fiSlS.. Experimental Serum Calcium Activity 
Syb!tra!;e Cons;tlt~sm 'mdl 'S'Ii!!Jbn& bonel 
Succinate-2,3-14c PTE 12.6 124 
14 Suceinate-2,3· C PTE 13.1 11S 
Suecinate-2,3-14c PTE 13.1 126 
14 Suecinate-2,3· C PTE•TCT 10.4 85 
Succ1nate-2,3-14c PTE-TCT 10.6 9S 
Suceinate•2,3·14c PTE•TCT IO.S 80 
Succinate-2,3·14c Control 9.6 70 
Suceinate-2,3-14c Control 9.9 75 
Succinate•2,3·14c Control 9.9 85 
iflP!!X§l~ Experimental Serum C&lelum Activity 
~l!J21Si£Atl Cgndi:ti!D hu&~l ';mn4ma bon!~ 
14 Suceinate-2,3· C PTE 12.6 1,200 
Suoeinate-2,3-14c PTE 13.1 1,190 
Succ1nate-2,3-14c PTE 13.1 1,210 
14 Succinate-2,3- C PTE•TCT 10.4 910 
Succinate-2,3-14c PTE-TCT 10.6 920 
Succinate-2,3-14c PTE•TCT 10.5 1,010 
14 Succinate-2.3· C Control 9.6 92S 
14 Succinate-2,3- C Control 9.9 9SO 
14 Succinate-2.3· C Control 9.9 960 
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E!2•riment 21: Ihe Iggubation of NAOP FO£t1f1!9 ftomoatnatea of 
5ont PreE!rftd from the Dia2hysis and EQiRhltia of PTI·Trtet~ 1 
PTE·TCT·Treatad and C?ntrol AnJ.m!ls witb 2-Qxoglutarate-s-14g. 
Six thyroparathyroidectamized antmala were used in the 
experiment. Twenty four hours after auraery, four of the six 
ant.als received 100 u.s.P. units each of Injection Parathyroid 
over a period of two days in two doses of SO units each. The 
two eontrol animals received no injeetiona. Twelve hours after 
the last doae of Injeetion Parathyroid• two of the four animals 
eaeh reaeiv.t 15 as of thyrocalcitonin TCA powder which waa 
administered in the form of two injections of one-half ml each 
over a two hour period. Serum calcium levels prior to sacrifice 
in the PTE-treated, PTE·TCT-treahlent ad contJ:ol animals 
averaged 13.1 ma~. 11.6 IJlS'I and 10.1 ms'Xt reapecti vely. 
Bone ha.ogenates were prepared and one-half microcurie of 
substrate was introduced into each flask aa well as 4. 0 ml of 
bone homogenate aad sixteen mieromoles of NAOP, The incubation 
was carried out at 37° C for three hours in a c:onataat tempera-
ture shaker water bath. 
The results of the exper~ent ahown in Table XXIII indicate 
that the bone prepared fr• the PTE-treated ani.Jaala producea a 
greater amount of 14co2 from. wbatrate, tban does bone prepared 
from PTE·TCT-treated animals. Proctuction of 14c~ frCJm 
aubstrate in bone prepared frora PTE•TCT-treated animals ia 
greater than that produced fr• coratrola. This pattel:'n is 
TABLE XXIII 78. 
EFFECT OF PARATHYROID EXTRACT ALONE AND PARATHYROID EXTRACT 
TOGETHER WITH THYROCALCITONIN IN VIVO ON THE LABELED CARf~N 
DIOXIDE PRODUCED FRC»t TH~ OXIDATIO'N'OF 2-0XOGLU'fARt\TE-5- C BY 
HOMOGENATES OF FEMUR DIAPHYSIS AND EPIPHYSIS FORTIFIED WITH 
NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHaTE 
DIAPHYSIS Experimental Serum Calcium Activity 
Substrate Condi.tion ~mg~} ~ c;emlm!5 bonel 
2-0xoglutarate-5-14c PTE 12.9 104 
14 2-0xoglutarate-5- C PTE 13.4 90 
14 2-0xoglutarate-5- C PTE 13.0 96 
14 2-0xoglutarate-5- C PTE·TCT 11.5 61 
14 2-0xoslutarate-5- C PTE•TCT 11.8 57 
2-0xoglutarate-5·14c PTE·TCT 11.5 55 
2-0xoglutarate-s-14c Control 10.0 33 
14 2-0xoglutarate-5- C Control 9.8 35 
2-0xoglutarate-5-14c Control 10.5 32 
.EPIPHYSIS Experimental Serum Calcium Activity 
Sy:2strat~ Qongit~2D ~m&Ztl ~c11J!:.Lms bon!l 
2-0xoglutarate-s-14c PTE 12.9 420 
2-0xoglutarate-5-14c PTE 13.4 415 
2-0xoglutarate-s-14c PTE 13.0 430 
2-0xoglutarate-5-14c PTE·TCT 11.5 380 
2-0xoglutarate-5-14c PTE·TCT 11.8 371 
14 2-0xoglutarate-5- C PTE-TCT 11.5 368 
2-0xoglutarate-5-14c Control 10.0 342 
14 2-0xoglutarate-5- c Control 9.8 386 
2-0xoglutarate-5-14c Control 10.5 372 
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obaervad in the preparations of both the diapn,ata and epiphyaia. 
II"'MI!S 22: tbt lJKN!tf!lg of MDP Forti fiE Hcaoapatea of 
l19t P£1R!tt4 ftll She P&•Rbf!i! !Dd Epipbfsls of PTI•Tf!!5td• 
rii·TCI•tnated yd Gsmtnl Ap\Ml! with Pnuyate-2-14g. 
Six thyroparathyro:ldec:t•ized animals wen used in the 
experiment. 'l'vety four hours after surgery • four of the s1.x 
an~als reoei~ 100 u.s.P, units each of Injection Parathyroid 
over a period of two days in doses of 50 unite each. The 
control animals received no iajec:tiODa.. Twelve hours after the 
last dose of Injection Parathyroid, two of the four antaala each 
received 15 •& of thyrocalcitonin TCA powder which waa adllinia-
tered tn the form of tvo injections of one-half al over a two 
hour period.. Serum caleium levels prior to aacrifiee in the 
PT!•trflated, PTI•TCT•trea1:1Deat and control animals averaged 
12.8 mg1., 10 .. 9 ma% and 9,7 mat. Z"Upectively. 
Bone homoaeft&tea were prepared and one-half microcurie of 
substrate waa introduced into eacm flask aa well aa 4 .. 0 al of 
bone hcaoaenate and sixteen aicr<~Dolea of MDP. The incubation 
was carried out at 37° C for three hours ill a constant t•pera• 
ture srut.ker water bath, 
The reaulta of the exper1aent aivan in Table XXIV indieate 
that the bone prepared frOIIl the PTE-treated anima. ls produees a 
&r~at:er a'liount of 14cv2 from aubatrat:e, than doea bone pr.euared 
14 fram PTI•TCT-treated anlmala. Production of co2 from substrate 
in bone prepared fro.·;~ ~~E·TCT-treated animals is greater than 
that produced frOID controls. Tbia pattern ia observed in 
the preparations of both the diaphysis and epiphysis. 
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TABLE XXIV .st. 
EFFECT OF PARATHYROID EXTRACT ALONE AND PARATHYROID EXTRACT 
TOGETHER WITH THYROCALCITONIN 1! .!1!.2 ON THE LABELfi CARBON 
DIOXIDE PRODUCED FROM THE OXIDATION OF PYRUVATE-2· C BY 
LABELED HCHOG~TES OF FEMUR DIAPHYSIS AND EPIPHYSIS 
g~£111111 Experlaental Ser:ta Calcium Activity 
Syl!I~E!Jil gcmdi~l- '•dl 'CDil/11 b&!l 
Pyruvate-2-14c PTE 12.6 101 
Pyruvate-2-14c PTE 13.0 102 
Pyz:uvate-2-14c PTE 12.8 98 
Pyruvate-2-14c PTI•TCT 10.7 74 
Pyruvate-2-14c PTE•TCT 11.3 80 
14 Pyru:vate-2- C PT.E•TCT 10.7 79 
Pyruvate-2-14c C01ttrol 9.6 23 
PyJ:uvate-2-14c Coat~:ol 9.8 21 
P)'Nvate-2-14c Control 9.7 25 
Ill PitS II Experlaent:al Serua Cale:1UM Aetlvlty 
b!IISEIS! g0Dd&Sl98 '•dl 'smalaa !!mtl 
Pyruvate-2-14c PTE 12.6 181 
14 Pyruvate-2- c PTE 13.0 190 
14 Pyt:uvate-2- C PTE 12.8 187 
Pyruvate-2-14c PTE•TCT 10.7 159 
Pyt:uvate-2-14c PTE•TCT 11.3 167 
Pyruvate-2-14c PTI•TCT 10.7 156 
Pyruvata-2-14c Control 9.6 124 
14 Pyruvate-2- c Control 9.8 114 
Pyruvate-2-14c Control 9.7 119 
CHAPTER IV 
DISCUSS IOR 
The work contained in thla dleaert:ation waa initiated in an 
attempt to explain the apparent dual metabolic reaponae to 
parathyroid extract injectlon which waa reported by Cohn (27). 
He indicated that epiphyaeal•metaphyaeal fauur slices prepared 
fro. PTI•treated rabbits aetabollzed alyeolyaia inter:aediatea 
to a areater extent than did c•parable eontrol preparations, 
while aS..ilar preparations showed a marked depression in the 
metaboll• of l.reba cycle intU~Dediatea. There is no poatulated 
mataboU.c pathway which could account for thla phencaenon. 
Yatea et al. (117) alao prelented evidence that PTE doea 
have a dual metabolic role 1.n bone tilsue. He ..,.ried the levela 
of endogenous PTH via peritoneal lava&•• After aacriflce of the 
lavaaed animal, the faaura W8re r.oved arad separated into 
metaphyses (trabecular boae) and diaphyaia (o•pact bone) in 
preparation for ineubation. By meaeurina citrate and lactate 
COilcentntiODa present ln tbe media, it vaa d-onatrated that 
citrate production vaa areater in the diap~aia and lactate 
production was areater in the metaphysis. 
The work indicates that the dual metabolic effect produced 
by the adainiatration of parathyroid extract mi&ht be explained 
by the cellular differtmCtea of e011pact and trabecular bone. The 
effects of PTH Gil citn.te productiOD an seen mainly in the 
diaphysis of the femur. The moat numerous cell type of the 
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diaphysis is the osteocyte althouah osteoblast• and osteoolasts 
are also present. The epiphyseal cell types include a mixture 
of mesenchyme cella, osteoblast•• oeteoelaats and ostaoeytes. 
ln seneral, the structure of the epiphysis ls less hi&hly 
organized than that of the diaphysis. 
Experiments presented by DeLona ( 3.5) eonfll!'ltutd the dual 
response ln boDe tleeue fraptmta. R.epreseatative experiments 
have been recalculated Oil the 'basta of opm of evolved C~/mg 
bone to facilitate c•pariaoa vU:h the expertaents described 
in thil dislartatlon. 
TABLE XXV 
R!SfP-S! OF BONE TISSUE FRAGHEJttS TO PTE•TREATKDT AS MANIFESTED 
BY co2 EVOLUTION Flt<»t lABELED SUISTJATE 
§ubatrtt• 
Citrate-1,5-14c 
tnatmas 
PTI 
CODtrol 
PTE 
Control 
PTE 
Coatrol 
Activity 
Diapb.yats 
IMZ.I b29! 
26 
50 
30 
43 
373 
230 
Activity 
Epiphysis 
e;mlma boge 
21 
11 
77 
S4 
883 
.583 
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In general, the response shown in the metaboltam of Krebs 
cycle acids (citrate aDd succinate) incubated with bone pre-
pared from PTE•tr:eated animals was that of a depression in 
14co
2 
evolution in the diaphysis and a at~lation in the 
epiphysis. However, this pattern is not observed during the 
14 incubation of pyruvate-2- C with comparable bone prepar:aticns. 
Since the structures of eompact and trabecular bone are 
quite different • haaoaenizaticm was aaplcyed to obtain more 
comparable and uniform preparations. The homogenized bone is 
not fully viable unless exogenous NADP is added. This fincU.ng 
was also reported by Mecca et al. (78). Results of the incn.sba• 
tiona of the labeled substrate with NADP fortified hoaogenates 
may be summarized as follows: 
TARLE XXVI 
RESf~SE or BONE H<MOOIMTI TISSUE TO PTE-TREATMENT AS MANIFESTED 
BY co2 EVOl.UTlON FRGi lABELED SUBSTRATE 
iubetntt 
14 Citrate-1,5- C 
Pyruvate-2-14c 
TreaS!!Mt 
PTE 
Control 
PTE 
Control 
PTE 
Control 
Activity Activity 
Diaphysis 
SJi!!lu ~tons 
Epiphysis 
s•lma bRU 
124 375 
S6 285 
1200 2495 
890 1985 
268 664 
208 378 
8.5. 
Tba metabolic pattern re.ultina fro. a coapariaon of the 
oxidation of Krebs cycle aeida by MDP fortified bone bGnlogen• 
atea prepared fr• PTE-treated and cntrol an1mala indicates an 
increase la 14co2 evolution fraa labeled substrate in both the 
diaphyeis and epiphysis preparation obtained frem the PTE• 
treated aatmala. Thla same pattern ia obserwd durin& the 
incubation of pyruvate·2-14c with a .. parable bone preparation. 
Tbe data indicate that the metabolic reapoBse of PTE ia 
probably a reflection of the differences in physical structure 
of trabecrular al'ld eoapaot .__e rather than a function of 
cellular distribution or unique metabolic pathways. The d1&• 
physis contains bi&hly oraanized Haversian ayateD wbich 
contalaa viable cella deep within the aineral matrix. Left 
iatact • it would take loaaer for ia~~ to diffuse into the cell 
in the Haveraian ayat•• than auob a dlffualoa in the structur-
ally 1esa oraaaized eplpbyala. Dlapbyaia coataina 1eaa viable 
cella on the aurlaee of the alaua1 than epipbyala. The 
epipl\yaia la the chief arovtna ancl r•odelina center of bone and 
coataiaa a blah cODeentratiOD of cellular uter1a1 ia the 
epipbyaeal plate area. Therefore dlffuaioa of isotope into the 
cella contained in eoapaet and trabecular boae probably proceeds 
at different rates if the tia.ue structure ia left relatively 
intact Which it would be in bone fa-apent preparations. Thia 
variable is eliminated by hoaaoaeaS.zina the bone tieaue to a 
8Jaall unlfon particle aize. 
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Bone tiaaue can incorporate citric acid aa well as other 
Krebs cycle oraanlo aoida into the mineral matrix. Thia occurs 
to a greater extent in reaorbina areas in the stable calcium 
ccmpartment. Krebs cycle acids are incorporated into the open 
apaoea in the partially resorbed crystal lattice. The diaphysis 
is mineralized to a greater exteDt tbaft the epiphysis in the 
relatively YOUR& animals used in these expert-ants. Therefore 
the diaphysis of the PTI•treated aniaal vlll tend to bind more 
tracer acid tban will the diap~sla of control animals, since 
PTE•treated animals have more resorbina sites. Tbia would 
effectively reduoe the amount of available tracer and thus &iva 
an erroneously low rate of metabolism in the diaphysis of PTE· 
treated animals. Haaoaenization will equalize the DUaber of 
broken crystal lattice sites in both PTE and control prepara-
tions, thu.a equalizia.a &Dy substrate biD41D& differences. 
Four aicraaoles/ml of haaoa•ate is the optimal concentra-
tion of MADP necessary to obtain a fully viable bone homoaeaate. 
At concentratiOl'la leas tban tbat •CR.ul1: 1 the ayataa ta apparently 
not seDsltlve to hormone treatment, or it will exhibit a 
different metabolic pattern. 
Evidence baa been presen~ed which indicates that the 
metabolic chana•• asaoclatecl with the .&du&iniatration of PTE are 
not a direct fuaction of PTH action. Purified PTH has no effect 
on clycolylia in Erhlich Ascites tumor cells. However, non-
hypercalca.ic fractions from the gel filtration purification 
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of PTE does have a metabolic response in this assay similar to 
that pro4uced by PTE (.52}. 
Aurbach et al. (8) has shown that several metabolic 
responses previously attributed to PTE aetion in kidney homo• 
genates• can be duplicated with non-hypercalcemic peptides. 
ln particular, the reported PTH•induced stimulation in ion 
transport and mitochondrial respiration believed to be involved 
in the mechanism of action of calcium homeostasis, can be 
duplicated in a comparable in yit£2 syat•~ usin& non-hyper-
calcemic fraetiona obtained durin& purification of parathyroid 
hormone as well as basic proteins such as polylysine and ?ro-
lami.ne. 
The alterations in metabolism produced by the injeetion 
of PTE can be meaaured up to 48 hours after injection. However 
the half-life of PTH bas been estimated to be 20 minutes. Even 
so, the serum calcium levels remain elevated 24 - 48 hours after 
a pharmacoloaical dose of PTE. 
To study the possible relation between the elevated levels 
of aerum calcium and metabolltm, bone ha.uo&enatea prepared ln 
media containina various concentraticma of calcium ion were 
incubated with pyruvate-2-14c. This substrate was chosen 
because of ita relatively central position in the metabolic 
pathways of bone. The results of the experiment are aummari.zed 
in Table XXVll. 
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TABLE XXVII 
IISPONSE OF BONE JiSSUE PREPAMTIOM TO JJ! YITIQ CALCIUM LEVELS 
AS MANIFESTED IY ~ EVOLUTION PlOH LABELED SUBSTRATE 
Madia ca++ 
Aeti'ri.ty Activity 
Diapbyala Epipbyaia 
l»l!ISDII till a•7ma :UU SWI!I 12!!!1 
Py&uvate-2-14c 14 q'J, 162 353 
Pywwte-2-14c 10 •&'~. 134 294 
14 Pyruvate-2• C 6 .,, 88 205 
Aa the aalcba ecmeeatrati.on of the aedlwa was i.ncreaaect fr 
6 q" to 14 ••"• the evolution of 14co2 waa laereaaed fr• 88 
cpa/aa boa• to 162 epa/raa bODe lll the dlaphyala and 205 cpa/a& 
to 353 opa/aa bone ln the eplpbyala. 
ln order to aaaertat.D whether or not the alteratiODa in 
aetaboll .. of pyruvate-2-14c produced ~ varyiaa 1a yitro calcium 
ion le.ela are eeaparable to the alteratlcma 1D aetaboll .. 
produced by varyl.aa .&a pD auum ealab.a1 bone tlaaue obtai.Ded 
fr• tbyroparat:byroldeotGal&ed t:'&ta aaiatalned em a aomal and 
a aalciua•deflcleat diet waa prepared for iaeubation (Table 
XXVlll). 
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TABLE XXVIII 
ESPONSE OF BONE I!SSUE PREPARATION TO .1l! !.UQ CALCIUM LEVELS 
S MANIFESTED BY co2 EVOLUTION FROM LABELED SUBSTRATE 
Activity Activity 
Averaae ++ Diaphysis Epiphysis 
lUt.!1 Strp C! sraZma l!n• s•lma bgpe 
Noxmal 10.6 •• ,. 123 370 
Caleb•· 8.5 •• ,. 93 225 
deficient 
The results indicate that the tissue prepared from tbe 
taala which have the lower aerua caloiua values also have a 
ower rate of bema metabolism. It does appear then, that the 
evela of calciUM can influence the rate of metabolism both 1a 
.-.. .... and iD :!lJ!2 
In order to elaborate on this pr.,ise, the rate of 
etabollam in antmala made hypercalcemic and hypocalcemic by 
treatment was W'ldertaktm. The initial aoal in this 
phase of the experimental work was to detenalne rates of meta• 
bollm in normal animals and animals lll&de hypocalc-ic by 
injection of thyrocalcitonin (TCT). Tbe re.ults of these 
experiments appear in Table XXIX. 
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TABLE XXIX 
RKSPOftSE OF1JONE TISSUE PREPARATION TO TCT·TREATMENT AS MAN-IFESTED BY C02 EVOLUTION PROM LABELED SUBSTRATE 
Subatrats 
14 Citrate-l,S- C 
C1trate-1,5-14c 
Control 9.3 
TCT 8.9 
Activity Activity 
Di&P.hyaia Epiph7aia 
s.Zu bne seZu bog• 
52 140 
so 140 
The data indicates that the 1light depression of serum 
calcium produced by the a4alniatration of the particular dose 
level of TCT has no aipificant effect on metabolism. Apparently 
metabolism ia sensitive only to lara• changes in calcium con• 
eentration. 
Animals are more sensitive to any given dose level of TCT 
if they are in a state of b¥perc:alcemia. In this regard, a 
greater sensitivity to TCT can be developed in animals by pre• 
treatment with PT!. The animals made hypercalcemic via PTE 
administration wi 11 show a area tar decrease in serum calcium 
than that decrease in serum ea lci\a produced by the same dose 
level of TCT injeetecl into an ani.Jilal WS.th normal serum ealciura 
level. 
The aeries of experiaents in the latter portion of the 
dissertation were desiped to study bcme metaboli• at three 
differet'lt levels of Ja. .!d.:!2 calciUII loa coraceratrations. The 
results of the experimet'lts appear in Table XXX. 
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TABLE XXX 
RESPONSE OF BONE TISSUE PREPARATION 1'0 PTE1tND P'!E \HTH SUBSEQUENT TCT·TR.EATMENT AS YJANllESTED BY C~ 1!VOLUTIOif FRQt 
LABELED SUBSTRATE 
Activity Activity 
I:YI!ISE•S! Ia!lm!Bt 
Average ++ Diapbyaia Epiphysis 
Ita 9! snplps bo!!• sial•& bema 
14 C1trate-1·1S· C PTE 13.3 q'& 100 182 
PTB•TCT 11.1 • .,. 56 128 
CODtrol 10.0 .. ,. 19 76 
Suecinate•2,3-14c PTE 12.9 ..... 121 1,200 
PTE•TCT 10.5 ·~ 86 946 
Control 9.8 •• ,. 76 945 
2-0xoslutarate-s-14c PTE 13.1 .,, 96 421 
PTE·TCT 11.6 -~ 57 339 
Control 10.1 ..... 33 366 
Pyruwte-2-14c PTE 12.8 .. ,. 100 186 
PTE·TCT 10.9 •• ,. 77 160 
COiltrol 9.7 •aft 23 119 
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The data indicates that the level of metabolic activity 
in the bone preparations of diaphysis and epiphysis seems to 
reflect the level of serum calcium. Hypercalcemia produced by 
injection of PTE is associated with increased bone metabolic 
activity compared to the control bone preparations with all 
substrates tested. Injection of TCT into teat animals made 
hypercalcemic by the administration of PTE appreciably reduced 
the hypercalcemia. Concomitant with the reduction in serum 
calcium, a reduction in metabolic activity of the bone prepara-
tions was also observed. 
CHAPTER V 
SUf'1HARY AND CONCLUSIONS 
1 t has been noted by numerous reaearobera that the 
administration of Parathyroid Extract to ~e~t animals ~r~duees 
a dual metabolic response in bone. The results of others aa 
well as the data pnsaDted in the beaini.D.a of the Experimental 
Chapter of this dissertation indicate tbat the oxidation of 
alycolytic intemediatea ia increased durin& the incubation of 
surviv1na fanur epi.pbyaia frapents while the oxidation of Kreba 
cycle lntez:medlates ia dillinlshed durin& the incubatloa of 
aurvivt.na f•ur diapbysia frapents. {Table XXV). However, 
wben the bone tisauee are hoaoaenlzed aad adequate a.ourats of 
MDP are &deled to reconstitute the syat• oae observes a 
at~ulatioa in the oxidation of both Krebs cycle and glycolytic 
intermediate in f..ur diaphysie and epipbyals prepared from 
PTE•treated antaala (Table XXVI). H•oseralzatioa of these 
tissues ainlad.zes the inherent physical and aubatrate bindin& 
differences wbicb aay account for the pattern observed in 
studies usina intact or frapeatt.aed e•paet aad trabecular bone. 
A consisteat patten of oxidat'ive reeponee to PTE is in iteelf 
aore lopeal thAD t'he pnviouely reported 'dual' aetabollc 
reaponse, since there are no recoanized aetabolic pathways which 
could account for the • dual 1 response. 
Coba &Del Forsoher: (26) reported that 851. of the total 
alucose present durlna ineubation with bone was oxidized via 
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glycolytic - Krebs-cycle pathways While 15~ was metabolized via 
the pentoae shunt. Therefore the majority of the labeled C~ 
produced frCIIl substrates durin& borte metaboli• ia c:lue to Kreba 
cycle acti:ri.ty. 
The metabolic activity of bone hoaoaenate la increased •• 
the level of 1a Jltrt calcium loa is increased (Table XXVII). 
Alao, bone h•oaenate prepared fraa thyroparathyroideetoml.zed 
antaala maintained on a ealeiua•deflcient diet show. a lower 
metabolic activity thaD bone haaoaenatea prepared fro. the 
thyroparathyroidect•ized rata aaintained on a normal diet 
(Table XXVIII). These ant.ala also maintained a lover serum 
calciua tb.ala did animals on a llOJ:aal dlet. 1 t appears that both 
1D vltro and !!1 .J1:l.t levels of calciua ion can influence bone 
metabolism. 
TCT aCS.lniatered to thyroparathyroidectOIIllZecl rata produces 
a very aliaht deereaae ln aerua calcium and baa no aiplf icant 
influence on bone metaboli .. (Table XXlX). However, if the 
same dose level of TCT ia lajeetecl iato an animal made 
hypercaleeaic by prior adaialatratlon of PTE, the reaultaat 
marked decrease in aeZ'Uil calclua ia aeeompanled by a ai&nlficant 
decrease la bone aetaboll• (Table XXX). The decrease in 
metaboll.. muat be a direct result of the decrease in aerum 
calclua since the adalaiatratitm of the ••• dose level to a 
nor,mal antmal produced a all&ht fall in serum calcium but no 
alpificant chana• in bone metaboliam. 
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The data presented in the dissertation is the first direct 
evidence of the influence of calcium ion concentration on the 
ox.idatiOD of substrates in bone. It has been d•onstrated that 
PTH does not influence the oxidat:ioa of 11\lbat:ratea ( S2). 
Current evidence indicates tbat this hormone initiates bone 
resorption by promoting the release and synthesis of bone des• 
troyiD& enzymes (38). In evaluatina the role of bone metabolism 
in the overall role of bone reaorptiOD and accretion, one mi&ht 
speculate that aa bone resorption proceeds, intracellular levels 
of calcium can increase. Increased intracellular levels of 
calcium durin& bone resorption can produce, according to the 
experimental evidence presented herein, an increase in bone 
metabolisa which in turn can produce a localized acidosis at 
the area of resorption. An acidic aedlum at the site of 
resorption will favor reaorption, since almost all of the bone 
destroying enzymes are acid hydrolaaes. TCT baa been shown to 
promote the accretion of calcium into bone. Calcium accretion 
will probably involve a decrease 1ft the intracellular levels 
of calcium. Such a decrease according to the data presented in 
the dissertation, will reduce the cellular acid products (ie. 
cellular acidity) and tbus diminish the activity of the acid 
hydro lases. 
In conclusion, one can state tbat bone metabolism is no 
lonser believed to be the prtmary eontrollin& mechanism of bone 
resorption and accretion •• proposed by Neuman and Meu.an (82). 
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However. it is poaaible ~hat the rate of bane metabolism as 
influenead by the intracellular calcium l•veta ean aet as a 
eeooradary control meehaftl• which pro'ri.dee an optlmal aeidie 
cellular l.tttdl\D for the ...,.,. •• of bone reaOE"ptlon. A stbu• 
lation ln metaboll88 produced by lnereaaed caleiua levels 
durlft8 reaorpt:lon. would favor resorption by eausins increased 
aeotaulatlon of tbe aeid products at metabolilll thus producina 
• loealized acidosis. The activity of the aeld hydrolase• 
involved ia resorptlOft would b4t l.l'lO'Nilsed ln the actdlo medium. 
This poaeulate mlaht aeoount for the fact that aeJ:Um calcium 
levels r ... tn elevated up to 24 • 30 hours after the injection 
of PTH e'Mft thouah the half life of the h.ctmone has been shown 
to be 20 •lautes. 
Corrvereelyt lajeotlcm of tb.yroealelt•lft will an:est bone 
resorption and the iratraeellular lewla of ealelua ion will 
probably deereaae. The decreased oxldatlw rate due to rela· 
tlvely low 1atraeellular ealelum lewla would retard the 
aecnaulatlon of the acid products of metabolism aod thus rata1'd 
the aott .S. cy of bone destroyiftg -.z,.es. 
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